ࡱ>  =?23456789:;<q` RIbjbjqPqPB::&$$$$$$$$8|6 T$X0L0"11123\30$0h9Y$>2"2>>9$$11}SSS>p $1$1S>SSGv$$Sz10 h *.Hx4{ Q0Kx$J$hSz$$Sz/4`6SA8\9/4/4/499CSX/4/4/4>>>>$$dZ&^$v$$Z&^$$$$$$$$$ Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2010 INTERIM RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company) hereby announces the unaudited consolidated results of the Company and its subsidiaries (the Group) for the half year ended 30 June 2010 (the Reporting Period). The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and PRC accounting standards. This results announcement (the Announcement) is summarised from the Companys 2010 interim report (the Interim Report) and investors are advised to read the full text of the interim report for full information. The Announcement is published in Chinese and English. The Chinese version shall prevail if there are discrepancies between the Chinese version and the English version. I. COMPANY INFORMATIONChinese Name of the Company : q\qge兡N gPlQSEnglish Name of the Company: SHANDONG XINHUA PHARMACEUTICALCOMPANY LIMITEDLegal Representative: Ms. Guo QinCompany Secretaries: Mr. Cao Changqiu, Ms. Guo LeiTelephone Number: 86-533-2196024Facsimile Number: 86-533-2287508E-mail Address of Company Secretaries: cqcao@xhzy.com, H HYPERLINK "mailto:guolei@xhzy.com" guolei@xhzy.comRegistered Address and Office Address: Chemical Industry Area of Zibo Hi-tech Industry Development Zone, Zibo City, Shandong Province, the Peoples Republic of China (the PRC)Postal Code: 255005Website of the Company: H HYPERLINK "" E-mail Address of the Company: H HYPERLINK "mailto:xhzy@xhzy.com" Uxhzy@xhzy.comUPRC newspaper for information disclosure: Securities TimesWebsite designated by the China Securities Regulatory Commission (the CSRC): H HYPERLINK "http://www.cninfo.com.cn" http://www.cninfo.com.cnListing InformationH SharesStock Exchange: The Stock Exchange of Hong Kong Limited (the SEHK)Abbreviated Name: Shandong XinhuaStock Code: 0719A SharesStock Exchange: Shenzhen Stock Exchange (the SZSE)Abbreviated Name: Xinhua PharmStock Code: 000756a!. SUMMARY OF FINANCIAL RESULTS(i) In accordance with PRC accounting standards (RMB)ItemAs at 30 June 2010(Unaudited)As at 31 December 2009 (the  End of Last Year )(Audited)Change as compared to the End of Last Year (%)Total assets2,796,099,567.062,626,187,060.386.47Total equity attributable to equity holders of Company1,637,660,330.731,633,645,846.350.25Capital457,312,830.00457,312,830.000.00Net assets per share attributable to equity holders of Company3.583.570.28Six months ended 30 June 2010(Unaudited)Six months ended 30 June 2009 (the Same Period Last Year)(Unaudited)Change as compared to the Same Period Last Year (%)Total operating income1,368,618,869.541,196,792,146.6414.36Operating profit71,140,908.6958,040,612.5022.57Profit before taxation74,980,507.5250,683,526.8947.94Profit attributable to the equity holders of Company57,881,893.6339,887,094.3345.11Profit attributable to the equity holders of Company after extraordinary items54,449,164.5838,401,542.2441.79Basic earnings per share 0.130.0944.44Diluted earnings per share 0.130.0944.44Return on equity (%)3.482.71Increase 0.77 pointsNet cash flow from operating activities136,981,964.64121,733,607.2612.53Net cash flow from operating activities per share 0.30 0.2711.11Note:Extraordinary items include:ItemAmount (RMB)Profit or loss from disposal of non-current assets 793,794.41 Government subsidies recognised in current profit and loss, (excluding those closely related to the Companys normal operations and granted on an ongoing basis under the national policies according to certain fixed quota of amount or volume) 4,447,696.50 Gains (losses) from fair value changes of trading financial assets and trading financial liabilities, and investment income from disposal of trading financial assets, trading financial liabilities and available-for-sale financial assets, except effective hedging activities related to the Companys normal operations 801,498.99 Other non-operating income or cost except the above items(1,401,892.08)Non-controlling interests(25,039.25)Income tax expense(1,183,329.52)Total 3,432,729.05 (ii) In accordance with HKGAAP (RMB000)Consolidated Income StatementItemSix months ended 30 June 2010Unaudited Six months ended 30 June 2009Unaudited Revenue1,352,5831,179,184Profit before taxation77,12649,776Income tax expense(13,904)(8,701)Profit for the period63,22241,075Includes: Profit attributable to owners of the Company60,17439,115Non-controlling interests3,0481,960Consolidated Statement of Financial PositionItemAs at 30 June 2010Unaudited As at 31 December 2009Audited Total assets2,798,035 2,636,363 Total liabilities(1,114,917)(955,542)Non-controlling interests(35,430)(36,318)Equity attributable to owners of the Company1,647,688 1,644,503 (iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAP (RMB) (Unaudited)ItemProfit attributable to the equity holders of CompanyTotal equity attributable to equity holders of Companythe Reporting PeriodSame Period Last YearAs at 30 June 2010As at 1 January 2010Prepared under HKGAAP60,174,000.0039,115,094.331,647,688,000.001,644,503,000.00Prepared under PRC accounting standards57,881,893.6339,887,094.331,637,660,330.731,633,645,846.35HKGAAP adjustments:Deferred taxation145,106.37136,000.00(1,771,330.73)(1,914,846.35)Depreciation charges due to revaluation in previous years - (204,000.00)(21,300,000.00)(21,300,000.00)Provision for education fund(973,000.00)(704,000.00)11,799,000.0012,772,000.00Surplus from revaluation for listing of H Shares -  - 21,300,000.0021,300,000.00Financial award for Energy-saving technological transformation 3,120,000.00 -  -  - Total of the difference between the PRC accounting standards and HKGAAP2,292,106.37(772,000.00)10,027,669.2710,857,153.65Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education fees are set out as per the actual circumstances, without the need of provision under HKGAAP. As at 30 June 2010, provision made for the balance of education fees under the PRC accounting standards was RMB11,799,000 with an amount in education fees of RMB973,000 for this period.2. The Company received financial award for energy-saving technological transformation of cash RMB3,120,000, which should be picked up to current profit of loss under HKGAAP, but which should be picked up to capital reserve under the PRC accounting standards. 3. Aforesaid difference also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax of RMB1,771,330.73 and that in deferred income tax of the current period of RMB145,106.37. III. CHANGES IN SHARE CAPITAL STRUCTURE AND INFORMATION ON SHAREHOLDERS1. Share Capital structure30 Jun 20101 Jan 2010Class of sharesNumber of shares (share)% of the total share capitalNumber of shares (share)% of the total share capital1. Total number of conditional tradable shares16,2230.004187,809,72541.07Stated-owned shares00164,207,42435.91Domestic legal person shares0000Conditional tradable senior management A shares16,2230.00423,3900.01Others0023,578,9115.152. Total number of unconditional tradable shares457,296,60799.996269,503,10558.93Renminbi ordinary shares (A shares)307,296,60767.196119,503,10526.13Overseas listed foreign shares (H shares)150,000,00032.80150,000,00032.803. Total number of shares457,312,830100.00457,312,830100.00Tradable Schedule of Conditional Listed Tradable Shares is as follows:Name of shareholdersNumber of shares subject to conditions of trading as at 1 January 2010Number of unconditional tradable shares between 1 January 2010 to 19 March 2010Increase in shares subject to conditions of trading between 1 January 2010 to 19 March 2010Number of shares subject to conditions of trading as at 19 March 2010ConditionsDate of plan removing the conditionsShandong Xinhua Pharmaceutical Group Company Limited(SXPGC)164,207,42420,221,5941,864,414145,850,244Special undertaking19 March 2010Qingdao Haowei Investment Development Company Limited15,000,0001,599,443(1,864,414)11,536,143Compliance with the special undertaking of SXPGC19 March 2010Zibo High-Tech Venture Capital Company Limited6,683,911813,86105,870,050Compliance with the special undertaking of SXPGC19 March 2010Huludao Bajiazi Mining Industry Company Limited1,550,000188,73401,361,266Compliance with the special undertaking of SXPGC19 March 2010Shangrao Daihu Industrial Company Limited345,00042,0090302,991Compliance with the special undertaking of SXPGC19 March 2010Name of shareholdersNumber of shares subject to conditions of trading as at 19 March 2010Number of unconditional tradable shares between 19 March 2010 to 30 June 2010Increase in shares subject to conditions of trading between 19 March 2010 to 30 June 2010Number of shares subject to conditions of trading as at 30 June 2010ConditionsDate of plan removing the conditionsSXPGC145,850,244145,850,24400Special undertaking7 June 2010Qingdao Haowei Investment Development Company Limited11,536,14311,536,14300Compliance with the special undertaking of SXPGC7 June 2010Zibo High-Tech Venture Capital Company Limited5,870,0505,870,05000Compliance with the special undertaking of SXPGC7 June 2010Huludao Bajiazi Mining Industry Company Limited1,361,2661,361,26600Compliance with the special undertaking of SXPGC7 June 2010Shangrao Daihu Industrial Company Limited302,991302,99100Compliance with the special undertaking of SXPGC7 June 2010Note 1: SXPGC has undertaken that between the 36th month and 48th month since the listing of the non-tradable shares of the Company (6 June 2006), the shares to be sold through the SZSE shall not exceed 5% of the total share capital of the Company, and it shall not sell any of its shares of the Company on the SZSE at a price less than RMB4.8 per share, (such price will be on an ex-rights basis if there is any declaration of dividends, bonus issues or capitalisation of capital reserve during the period between the day of implementation of the revised share reform of the Company and sale of the shares by SXPGC) being 150% of the average closing price of the listed A Shares as quoted on the SZSE in the thirty (30) trading days prior to the issuance date of the relevant notice of the shareholders meeting. Should SXPGC breach any of the provisions of this undertaking in the sale of its shares, the proceeds resulting from such sale shall be owned by the Company.Note 2: According to the Shandong Provincial State-owned Assets Supervision and Administration Commission Lu Guozi Kaoping document No. (2007) 60, SXPGC recovered 1,864,414 shares from Qingdao Haowei Investment Development Company Limited through a judicial auction. The transfer procedures were completed in the China Securities Depository and Clearing Corporation Limited Shenzhen Branch on 7 January 2010.2. As at 30 June 2010, the Company had on record a total of 40,445 shareholders, including 58 holders of H Shares and 40,387 holders of A Shares.3. As at 30 June 2010, the ten largest shareholders of the Company were as follows: Unit: shareNumber of ShareholderTypes of shareholdersNumber of shares held% of the total share capitalNumber of conditional tradable shares heldNumber of shares being charged or frozenSXPGCState-owned shareholder 166,071,83836.3100HKSCC (Nominees) LimitedH shares shareholder147,309,99832.2100Qingdao Haowei Investment Development Company LimitedDomestic general legal person11,536,1432.52011,250,000Zibo Hihg-Tech Venture Capital Company LimitedDomestic general legal person6,683,9111.4600China Bank Jingshun Changcheng Dongli Pingheng Security Investment FundFund4,499,9040.9800Huludao Bajiazi Mining Industry Company LimitedDomestic general legal person1,550,0000.3400Liu JinhaoDomestic person1,020,0550.2200Chongqing International Trust Company LimitedDomestic general legal person1,000,0000.2200DA ROSA JOSE AUGUSTO MARIAH shares shareholder1,000,0000.2200GUOSEN-China Merchants Bank Guoxin Cash financial return swap (multiple strategies) asset management plansFund810,5600.18004. As at 30 June 2010, the ten largest shareholders of the unconditional tradable shares of the Company were as follows:Name of ShareholderNumber of unconditional listed shares (share)Class of sharesSXPGC166,071,838A SharesHKSCC (Nominees) Limited147,309,998H SharesQingdao Haowei Investment Development Company Limited11,536,143A SharesZibo Hihg-Tech Venture Capital Company Limited6,683,911A SharesChina Bank Jingshun Changcheng Dongli Pingheng Security Investment Fund4,499,904A SharesHuludao Bajiazi Mining Industry Company Limited1,550,000A SharesLiu Jinhao1,020,055A SharesChongqing International Trust Company Limited1,000,000A SharesDA ROSA JOSE AUGUSTO MARIA1,000,000H SharesGUOSEN-China Merchants Bank Guoxin Cash financial return swap (multiple strategies) asset management plans810,560A SharesNote:1. The Directors are not aware as to whether there is any association amongst the ten largest shareholders of the Company, nor the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies issued by the China Securities Regulatory Commission (the CSRC). In addition, the Directors do not know whether there is any association amongst the shareholders of H Shares of the Company or persons acting in concert as referred to above. The Directors do not know whether there is any association amongst the ten largest shareholders of unconditional tradable shares of the Company, any association between the ten largest shareholders of the Company or the persons acting in concert as defined in the Rules for the information Disclosure of Changes in the Shareholding of Listed Companies issued by the CSRC.2. The only domestic shareholder with more than 5% of the total issued shares of the Company is SXPGC.3. There was no change of controlling shareholder of the Company during the Reporting Period.4. Save as disclosed above and so far as the Directors are aware, as at 30 June 2010, no other person (other than the Directors, supervisors of the Company (the Supervisors), chief executives or members of senior management of the Company (the Senior Officers)) had an interest or short position in the Companys shares or underlying shares (as the case may be) which would fall to be disclosed to the Company and the SEHK under the provisions of Divisions 2 and 3 of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong (SFO) and as recorded in the register required to be kept under section 336 of the SFO), or was otherwise a substantial shareholder (as defined in the Rules Governing the Listing of Securities on the SEHK (the Listing Rules)) of the Company.IV. DIRECTORS, SUPERVISORS AND SENIOR OFFICERSThe number of shares held by the Directors, Supervisors and Senior Officers of the Company were as follows:NamePositionNumber of Shares(share) as at 1 January 2010Change in number of SharesNumber of Shares(share) as at 30 June 2010Directors:Ms. Guo QinChairman9,479Nil9,479Mr. Liu ZhenwenNon-executive DirectorNilNilNilMr. Ren FulongExecutive Director, General ManagerNilNilNilMr. Zhao SongguoExecutive Director, Deputy generalmanager & Financial ControllerNilNilNilMr. Li TianzhongNon-executive Director (resigned on 9 April 2010)NilNilNilMr. Xu LieNon-executive Director (appointed on 25 June 2010)NilNilNilMr. Zhao BinNon-executive Director NilNilNilMr. Zhu BaoquanIndependent non-executive DirectorNilNilNilMr. Sun MinggaoIndependent non-executive DirectorNilNilNilMr. Kwong Chi Kit, VictorIndependent non-executive DirectorNilNilNilSupervisors:Mr. Yu GongfuChairman of Supervisory Committee6,075Nil6,075Mr. Li TianzhongSupervisor (appointed on 25 June 2010)NilNilNilMr. Liu QiangSupervisor4,370Nil4,370Mr. Zhang YueshunIndependent SupervisorNilNilNilMr. Tao ZhichaoIndependent SupervisorNilNilNilSenior Officers:Mr. Zhang DaimingDeputy General ManagerNilNilNilMr. Dou XuejieDeputy General ManagerNilNilNilMr. Du DeqingDeputy General Manager NilNilNilMr. Du DepingDeputy General Manager NilNilNilMr. Cao ChangqiuCompany Secretary1,708(427)1,281Ms. Guo LeiCompany SecretaryNilNilNilTotal21,632Nil21,205All shares held by the Directors, Supervisors and Senior Officers are A shares. The changes in the number of shares held by the Directors, Supervisors and Senior Officers were due to the shares sold on the secondary market according to relevant provisions.So far as the Directors, Senior Officers and Supervisors are aware, save as disclosed above, as at 30 June 2010, no Director, Senior Officer or Supervisor had any interest or short position in the shares, underlying shares and / or debentures (as the case may be) of the Company or any of its associated corporations (as defined in Part XV of the SFO) which was required to be notified to the Company and the SEHK pursuant to Divisions 7 and 8 of Part XV of the SFO (including any interest or short position which any such Director, Senior Officer or Supervisor is taken or deemed to have under such provisions of the SFO) or which was required to be entered in the register required to be kept by the Company pursuant to Section 352 of the SFO or which was otherwise required to be notified to the Company and the SEHK pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers as contained in Appendix 10 to the Listing Rules.CHANGES OF DIRECTORS, SUPERVISORS AND SENIOR OFFICERSMr. Li Tianzhong resigned as a non-executive director of the Company with effect from 9 April 2010 due to a change of job.Mr. Xu Lie was appointed as a non-executive director of the Company and Mr. Li Tianzhong was appointed as a supervisor of the Company in the annual general meeting held on 25 June 2010.V. CHAIRMANS STATEMENTDear shareholders,I am pleased to report the operating results of the Company for the six months ended 30 June 2010.For the six months ended 30 June 2010, pursuant to the PRC accounting standards, the operating income of the Group was RMB1,368,619,000 and net profit attributable to equity holders of the Company was RMB57,882,000, representing an increase of 14.36% and an increase of 45.11% respectively, as compared to that of the same period last year.The Group had a turnover of RMB1,352,583,000 and the profit attributable to owners of the Company of RMB60,174,000 for the six months ended 30 June 2010 under HKGAAP, representing an increase of 14.70% and an increase of 53.84% respectively, as compared with that of the same period last year.The Board did not recommend the payment of an interim dividend for the six months ended 30 June 2010.BUSINESS REVIEWDuring the first half of 2010, the Group aggressively made use of opportunities in pharmaceutical market and accomplished the business objectives set at the beginning of the year by overcoming various difficulties, adapting itself to policy changes in the domestic pharmaceutical market. Below is the business review of the Group for the period:1. Aligning itself to new situations and vigorously exploring domestic and overseas markets During the first half of 2010, the Company enhanced communications with its key customers (including through customer visits) to deepen cooperation and build up long-term strategic partnerships with them, with an aim to further consolidating and improving the market position of its key and strategic products. Taking advantage of the selling peak in principal pharmaceutical raw materials, the Company made great efforts to open up the market in the first half of 2010. As a result, the Companys domestic sales and export sales of pharmaceutical raw materials for the period grew rapidly by 23.06% and 17.49% respectively, over the same period last year. In line with new policies and changes with respect to national essential drugs such as zero mark-up and provincial tendering, the Company spared no effort in building its sales outlets and marketing teams for its preparation products as well as controlling operational risk. As such, sales of its preparation products increased 4.29% over the same period last year. 2. Steadily pushing forward industrial zone deployment strategy The Company has adhered to the principle of centralised planning, staged implementation, project-based advancement and rolling development in determining the layout for the four industrial zones and pushing forward construction and development of the new parks. During the first half of 2010, the overall planning of Hutian Park was completed, while the Phase`!relocation project completed the design work and was under pre-construction preparation. The Company will push forward with the construction of Hutian Park to build it into a  modern industrial base for chemical pharmaceuticals by the Company. Aiming at developing a circular economy demonstration zone, Shouguang Park will be built into a fine chemical industrial base. Following the commencement of the commercial production for various pharmaceutical intermediate projects such as chloro-propionyl chloride and violuric acid last year, the diketene and pyrazolone projects were also put into production in the first half of this year. In addition to satisfying the Companys need for the production of bulk pharmaceuticals, Shouguang Park, leveraging on the Companys brand and quality strengths, also achieved substantial growth in external sales and maintained a healthy growth momentum by actively exploring domestic and overseas markets. 3. Transforming growth mode and adjusting development structureThe Companys product mix was optimised and upgraded. After obtaining the GMP certification, the new production line of Ibuprofen actively utilised its production capacity within a short time period and recorded a double year-on-year growth in its domestic sales. The Companys distinctive raw material drugs achieved admirable production and sales results. The levodopa raw material drug, a new product, exceeded its sales target for the first half of 2010. Shandong Xinhua Pharmaceutical (Europe) GmbH fulfilled its role as being at the forefront of the European market and recorded 136.1% year-on-year growth in revenue. Projects at Shouguang Park were put into production in tandem which will become a new growth driver for the Company. Calcium polycarbophil, a new drug in category 3, has obtained, and a number of new drugs are in the process of applying for, clinical approval from the State Food and Drug Administration. The Companys success in processing and producing preparation products for Bayer in Germany resulted in economic benefits and enhancements in quality control and brand imaging. Based on this the Company made progress in seeking new business partners. 4. Enhancing internal management to improve quality and lower costWe continued to carry out the technical breakthrough campaigns double growth and double save and one tactics for one product and strived to improve technical and economic indexes of products by optimising craftsmanship and upgrading technology. As a result, the Companys raw material consumption for the first half of 2010 was reduced by RMB6,545,000 from the same period last year.Quality system and site management were further improved. Various products including Ibuprofen have successfully obtained GMP certification. We further increased investment in technical renovation in energy saving and emission reduction. The application of Four New technologies was promoted, and the energy online management system independently developed by the Company was optimised, including the internal waste water online measurement system. For the first half of 2010, the Companys energy consumption per RMB10,000 production value decreased 9.34% over the same period last year, bringing energy saving of approximately RMB7,052,000 for the Company. PLANS FOR THE SECOND HALF OF THE YEAR 2010In the second half of 2010, the Group is facing new challenges arising from the enforcement of the new Pharmacopoeia of the PRC, the new GMP to be promulgated and implemented, changes in the States pricing policy for pharmaceutical products and rules for tender management, as well as the export tax rebate rate reduction and the fluctuation in the RMB exchange rate as a result of the changes in the macroeconomic policy. The Group will assign staff to study and formulate practical measures and use its best endeavours to put into effect such measures. For the second half of the year, we will focus on the following:1. Seize opportunities by intensifying efforts to open up the market of our productsIn order to expand its sales, the Group will continue to consolidate and strengthen its position in the traditional product market by enhancing its association with customers and actively exploring the emerging markets. Taking advantage of the approval of the bulk pharmaceutical raw material, Ibuprofen and Levodopa by the U.S. FDA, the Group will explore every possible measure to tap into the international market with a view to further cementing the Companys leading position in the antipyretic and analgesic drug markets. The Group will explore its target markets by reinforcing its market position in preparation products, strengthening the terminal network building and team building as well as formulating practical market development measures in accordance with product features and market characteristics.Moreover, the Group will further improve and strictly implement the risk control system so as to reduce operational risk and optimise economic performance. 2. Further our plans for our industrial zones under which any structural adjustment schemes will be drawn on the basis of the strategy underpinning the industrial zones The Company will actively press ahead with the construction of the Hutian Park Project with reference to the master plan and the actual condition of the Company, and complete the preparation and construction of the relocation and renovation of the 10,000-tonne Aspirin materials project. It will also continue the production and operation of existing products in Shouguang Park, coordinate any facilities and external distribution in respect thereof and expand the production capacity of Shouguang Park through complementation and with reference to market demand. Efforts will be made in kick-starting the production of sulfuric acid and other products with an unwavering commitment to a cyclic economy. 3. Finalise the Companys 12th Five-Year Plan to set clear future targetsWith more than 6 months of organisation, discussion and preparation, the Company completed the draft of its 12th Five-Year Plan. In the second half of the year, the Company will focus on revisiting and finalising its five-year plan to set specific targets and formulate initiatives for the Companys development over the next five years and in the near future. 4. Further initiate Lets Improve Quality campaign to win market share by quality To adapt to the enforcement of the new Pharmacopoeia and the promulgation and implementation of new GMP in the PRC, to meet international certification requirements for its products and cater to high-end customers needs for higher quality products, the Company will further initiate the Lets Improve Quality campaign in the second half of the year, on top of the related promotional activities launched in early June this year in a bid to enhance the overall quality management of the Company. VI. MANAGEMENT DISCUSSION AND ANALYSISThe Group is mainly engaged in the development, manufacturing and sale of bulk pharmaceuticals, pharmaceutical preparations, chemicals and other products. The profit of the Group is mainly attributable to these businesses.1. LIQUIDITY AND ANALYSIS OF FINANCIAL RESOURCES AND CAPITAL STRUCTURE UNDER HKGAAPAs of 30 June 2010, the liquidity ratio of the Group was 174.70%, the quick ratio was 131.10%, the turnover ratio of account receivables was 424.54% (turnover ratio of account receivables = turnover / average account receivables and net value of bills x 100%) and the turnover ratio of inventory was 336.50% (inventory turnover ratio = cost of sales / average net value of inventory x 100%).There was no significant seasonal effect on the capital demand of the Group.The main source of funds for the Group was loans from financial institutions. As at 30 June 2010, the total amount of bank loans was approximately RMB443,620,000, which was floating rate loans and was accounted by HIBOR and rates issued by Bank of China. As at 30 June 2010, cash on hand and in bank amounted to approximately RMB486,245,000 (including bank acceptance drafts deposits of approximately RMB74,716,000).The Group has stringent internal control systems for cash and fund management in order to strengthen financial management. The Group has sound liquidity and repayment ability.The Group did not have any significant investment, acquisitions or asset disposals during this reporting period.The clarification of the performance results of the Group is referred to in the section headed Results and Financial Analysis under PRC accounting standards.As at 30 June 2010, the number of employees of the Group was 5,289. The total salaries for employees in the first half of 2010 amounted to RMB84,588,000.It is expected that there will be no significant investment projects in the second half of 2010.As at 30 June 2010, the capital debt ratio of the Group was 26.92% (capital debt ratio = total borrowings / equity attributable to owners of the Company x 100%).The cash and bank balances of the Company will mainly be used as working capital for production, operation and research development.The assets and debts of the Group were denominated in Renminbi. However, the Group achieved USD74,164,000 in its export for the first half of 2010. Therefore, there was a greater impact from foreign exchange. The Group adopted the following measures to minimise the foreign exchange fluctuation risk: 1. raising the export price in order to minimise foreign exchange fluctuation risk; 2. when the Group enters into an export contract involving large quantities of products with other parties, the Group shall seek prior consent from the other party that both parties will bear the foreign exchange fluctuation risk should the foreign exchange fluctuation exceed the contractual limit as agreed by both parties; and 3. actively striving for using RMB as a currency for settlement with overseas customers.2. RESULTS AND FINANCIAL ANALYSIS UNDER PRC ACCOUNTING STANDARDSIn the first half of 2010, the Group had achieved a turnover of RMB1,368,619,000 from its principal business, representing an increase of 14.36% as compared to the same period last year. The increase in revenue from the principal business was mainly attributable to the Company taking advantage of the selling peak in principal pharmaceutical raw materials, the Company made great efforts to open up the market in the first half of 2010 and the Companys domestic sales and export sales of pharmaceutical raw materials for the period grew rapidly by 23.06% and 17.49% respectively, over the same period last year. The increase in net cash and cash equivalents was RMB47,131,000, while there was an increase of RMB60,982,000 in the same period last year. The main reason for the change was that the increase in net cash outflow from investing activities was RMB26,586,000 as compared to the same period last year. Operating profit amounted to RMB71,141,000, representing an increase of 22.57% as compared to the same period last year. The main reason for the increase was that the Group actively expanded new markets and the leading products sales increased. At the same time it controlled purchase costs, reduced the consumption of raw materials and power and increased the product gross profit margin.Total assets of the Group as at 30 June 2010 amounted to RMB2,796,100,000, representing an increase of RMB169,913,000 or 6.47% as compared to the figure of RMB2,626,187,000 as at 1 January 2010. This increase was mainly due to an increase in cash during the Reporting Period. The Groups bank loans as at 30 June 2010 was RMB443,620,000, representing an increase of RMB49,596,000 from RMB394,024,000 at the beginning of this year. Such increase was attributable to cash borrowed by the Company from the bank to ensure supply of funds for production and projects construction. The Company has obtained part of the loan during the reporting period. Total equity attributable to equity holders of the Company as at 30 June 2010 overall increased by RMB4,014,000 or 0.25%, from RMB1,633,646,000 at the beginning of this year to RMB1,637,660,000. This change was mainly attributable to (1) an increase of RMB57,882,000 from the operating profit of the Group during the Reporting Period; (2) a decrease of RMB33,299,000 in the fair value of financial assets available for sale of the Group; and (3) a deduction of RMB22,866,000 from the total equity attributable to equity holders of the Company due to the distribution 2009 annual cash dividend.An analysis of the Groups turnover from principal operations is as follows (RMB000):By geographical location of customersFirst half of 2010First half of 2009Total turnoverCostsTotal turnoverCostsPRC (incl. Hong Kong)881,518721,942790,429663,648Europe166,175127,086119,18193,602Americas243,950203,246148,959118,730Others52,74939,509116,41176,369Total1,344,3921,091,7831,174,980952,349By industry and By productIncome from principal operationsCosts of sales of principal operationsGross profit margin(%)Bulk pharmaceutical 732,191  579,643 20.83Preparations 255,126  180,568 29.22Medical commercial logistics 329,306  312,121 5.22Chemical products and other products 27,769  19,451 29.95Total 1,344,392  1,091,783 18.79An analysis of profit as compared to 2009 is as follows:ItemsAmount (RMB000)% of total profitJan.-Jun. 20102009Jan.-Jun. 20102009Operating profit 71,141  135,909 94.88113.85Profit/Loss from non-operation activities 3,840 (16,535)5.12(13.85)Profit before taxation 74,981  119,374  100.00  100.00 Analysis of the reasons for changes: the percentage of the net non-operation income attributable to the total profit of the Reporting Period has seen a more substantial change because the Company has written off fixed assets of RMB19,606,000 during last year.3. USE OF PROCEEDSOn 3 September 2001, the Company raised an amount of RMB370,517,000 from the public offer and issue of 33,000,000 A Shares (including the sale of 3,000,000 State-owned shares). As at 30 June 2010, RMB332,415,000 were used in the following projects: Name of projectPlanned investmentRMB000Actual investment Jan.-Jun. 2010RMB000Accumulated amount of investmentRMB000% of the investmentRemarksState-level technical center renovation74,5001,44622,48230.18%-Injection GMP renovation80,000-80,226100.28%completedCaffeine technical renovation160,000-188,201117.63%completedL-350 technical renovation29,980-23,44278.19%completedAnalgin GMP renovation39,800-46,265116.24%completedTotal384,2801,446360,616-RMB28,201,000 financed by the Company(1) Injection GMP renovation project did not reach its profit forecast due to the decrease in pharmaceutical prices.(2) Caffeine technical renovation did not reach its profit forecast because of the effects of the drop in the price and the export tax rebate rate.(3) The main project of the renovation of the state-level technical center has been completed.The remaining proceeds were deposited with banks and will be used in accordance with the Companys project commitments.VII. REVIEW OF MAJOR EVENTSSave as disclosed herein:1. There is no material deviation between the actual corporate governance implemented by the Company and the rules and requirements of corporate governance required to be observed by listed companies in the PRC.2. The Board did not recommend the payment of any interim dividend, nor any transfer from reserves to share capital, for the year 2010.3. The Group was not involved in any material litigation or arbitration, whether pending or threatened during the reporting period.4. There was no material purchase of assets or disposal of the Companys assets, nor did any material mergers or acquisitions involving the Company occur during the Reporting Period. Similarly, no transactions of such nature occurred during the last reporting period and were carried over to the Reporting Period.5. During the Reporting Period, there was no trust, subcontract and lease of the assets between the Company and other companies.6. The independent non-executive directors special explanation and independent opinions in respect of the use of funds by related parties and external security provided are as follows:The Company was in strict compliance with the regulations of the notice Zhengjianfa [2003] No.56 issued by the CSRC and there was no non-operational use of the Companys funds by the controlling shareholder and other related parties.During the Reporting Period, there was no material guarantee provided by the Company, nor has there been any obligations that have not been performed in full by the Company. The Company was in strict compliance with the regulations of the notice Zhengjiafa [2003] no. 56 issued by the CSRC and there were no guarantees provided by any controlling shareholders, non-legal entity or individuals which were prejudicial to the interests of the Company and the shareholders, in particular the minority shareholders, of the Company. As at 30 June 2010, the Company had no overdue external guarantee debts and the Company had no liability arising from any guarantee due to the default of a guaranteed party.7. The Company and its shareholders holding more than 5% of total number of issued shares of the Company have provided undertakings for information disclosure as follows:(1) Within the period between the 36th to the 48th month from the listing date of the A Shares of the Company, SXPGC shall not sell any of its A shares of the Company on the SZSE at a price less than RMB4.8 per share (such price will be on an ex-rights basis if there is any declaration of dividends, bonus issues or capitalisation of capital reserve during the period between the day of implementation of the revised share reform of the Company and sale of the shares by SXPGC), being 150% of the average closing price of the listed A Shares as quoted on the SZSE in the thirty (30) trading days prior to the issuance date of the notice of relevant shareholders meeting. Should SXPGC breach any of the undertakings, the proceeds resulting from such sale shall be transferred to the account of the Company and owned by the Company.(2) As at 1 January 2006, SXPGC owed the Company the sum of RMB9,507,000 for non-business purposes. SXPGC repaid the capital by 30 June 2006 by way of cash. SXPGC guaranteed not to use any capital of the Company starting from 1 January 2006 for non-business purposes.8. Purchase, Sales and Redemption of the Companys listed securitiesDuring the Reporting Period, neither the Company nor its subsidiaries purchased, sold or redeemed any of its securities.9. Management of FundsDuring the Reporting Period, the Company did not appoint any person to manage the Companys funds. No such appointment was made in the preceding reporting period and carried over to the Reporting Period.10. Information about holding other listed companies (RMB)Stock CodeAbbreviated NameInitial investment amountProportion of equity interest in investeeBook value of end of the Reporting PeriodProfit/loss in the Reporting PeriodChange of shareholders equity in the Reporting PeriodAccounting coursesShare source601601China Pacific Insurance7,000,000.000.06%113,850,000.00-(24,956,480.00)Available-for-sale financial assetsPurchase601328BANKCOMM14,225,318.000.02%44,906,720.00747,200.00(14,250,000.00)Available-for-sale financial assetsPurchase600831BC & TV Network463,655.000.01%-54,298.9931,067.00Available-for-sale financial assetsAdjudicationTotal21,688,973.00-158,756,720.00801,498.99(39,175,413.00)--11. Index of important information which has been disclosedThe announcement of the 2009 Annual Results Announcement was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 12 April 2010.The announcement of the The First Quarter Report of 2010 was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 29 April 2010.The announcement of the The Notice of Annual General Meeting for the 2009 was published on the HKExnews, in the Securities Times in the PRC, on the website: http://www.cninfo.com.cn and on the Companys website on 10 May 2010.The announcement of the Announcement of 2009 Annual General Meeting Resolutions was published on the HKExnews, in the Securities Times in the PRC, on the website: http:// www.cninfo.com.cn and on the Companys website on 28 June 2010.12. Information of reception research, communication and interview during the Reporting PeriodReception timeReception locationReception methodReception objectsMain content of the discussion and the information provided11 May 2010Office address of the CompanyField studyHong Kong VL Asset etc.Understand the production and operation of the Company13 May 2010Office address of the CompanyField studyChang xin Fund etc.Understand the production and operation of the CompanyVIII. CORPORATE GOVERNANCECOMPLIANCE WITH THE CODE ON CORPORATE GOVERNANCE PRACTICESThe Directors confirmed that the Company was in compliance with the Code on Corporate Governance Practices (the Code) and has not deviated from the Code during the six months ended 30 June 2010. The Code includes the provisions contained in Appendix 14 to the Listing Rules.AUDIT COMMITTEEThe Company set up the audit committee under the Board in accordance with Rule 3.21 of the Listing Rules.The audit committee along with the management of the Company has reviewed the accounting standards, principles and methods adopted by the Group, and considered matters regarding auditing, internal control and financial reporting including the unaudited interim accounts for the six months ended 30 June 2010.The audit committee agreed to the accounting standards, principles and methods adopted by the Group for the unaudited interim accounts for the six months ended 30 June 2010, and it has been disclosed fully.INDEPENDENT NON-EXECUTIVE DIRECTORThe Company has complied with Rules 3.10(1) and 3.10(2) of the Listing Rules relating to the appointment of a sufficient number of independent non-executive directors and at least one independent non-executive director with appropriate professional qualifications, or accounting or related financial management expertise. The Company has appointed three independent non-executive directors including one with financial management expertise; details of their biographies were set out in the 2009 Annual Report of the Company.MODEL CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS OF LISTED ISSUERS (MODEL CODE)During the Reporting Period, the Company has adopted a code of conduct regarding transactions by Directors on terms no less exacting than the required standards set out in the Model Code. After having made specific enquiries to the Directors and Supervisors, the Company has confirmed that during the Reporting Period, all Directors and Supervisors have complied with the required standard set out in the Model Code in relation to directors securities transactions and they did not have any non-compliance with the Mode Code. h!. FINANCIAL REPORTS1. Profit and loss account prepared in conformity with PRC accounting standards (Unaudited) Unit: RMBItem First half of 2010First half of 20090ConsolidatedParent companyConsolidatedParent company1.Total operating income1,368,618,869.54 919,627,165.93 1,196,792,146.64 784,725,133.18 Includes: Operating income1,368,618,869.54 919,627,165.93 1,196,792,146.64 784,725,133.182.Total operating costs1,301,110,155.78 868,429,433.07 1,151,722,488.27 743,297,685.20 Includes: Operating cost1,117,047,193.39 740,266,357.99 976,473,336.24 626,225,077.32 Taxes and surcharges7,349,609.91 6,390,089.53 6,933,122.86 5,664,525.82 Selling expenses89,541,312.71 45,366,864.74 79,536,761.31 34,821,029.72 Administrative expenses77,263,090.21 65,903,825.12 73,492,127.93 61,543,421.68 Financial expenses9,908,949.56 10,502,295.69 15,287,139.93 15,043,630.66 Assets Impairment loss -  -  - - Add: Gain or loss from changes in fair value -  - 6,898,720.38 6,687,079.08 Investment gain or loss3,632,194.93 7,173,643.44 6,072,233.75 8,075,783.75 Includes: Investment gain or loss from related ventures and joint ventures2,822,345.26 2,822,345.26 3,822,703.75 3,822,703.75 Exchange gain or loss -  -  - -3. Operating profit71,140,908.69 58,371,376.30 58,040,612.50 56,190,310.81 Add: Non-operating income5,524,758.33 1,408,050.15 911,199.91 776,873.19 Less: Non-operating cost1,685,159.50 1,591,481.52 8,268,285.52 8,156,158.42 Includes: Loss from the disposal of non-current assets153,790.74 153,790.74 5,174,106.18 5,162,269.374. Profit before taxation74,980,507.52 58,187,944.93 50,683,526.89 48,811,025.58 Less: Income tax expense14,050,412.21 9,064,482.14 8,836,807.36 8,334,531.975. Profit after taxation60,930,095.31 49,123,462.79 41,846,719.53 40,476,493.61 Includes: Profit attributable to the equity holders of the parent company57,881,893.63 49,123,462.79 39,887,094.33 40,476,493.61 Minority interest3,048,201.68  - 1,959,625.20 -6. Earnings per share000 1) Basic earnings per share0.13 0.11 0.09 0.09 2) Diluted earnings per share0.13 0.11 0.09 0.097.Other comprehensive income(31,444,742.13)(30,179,101.05)75,135,767.43 75,063,089.288. Total comprehensive income29,485,353.18 18,944,361.74 116,982,486.96 115,539,582.89 Includes: Total comprehensive income attributable to the equity holders of the parent company26,880,125.88 18,944,361.74 115,024,394.30 115,539,582.89 Total comprehensive income attributable to the minority interest2,605,227.30  - 1,958,092.66  - NOTES:xe "s, 1. compared with the latest annual reportA th"1. During the Reporting Period, there was no change in accounting policies and accounting estimates.xe "nfluences, 2. in the range of consolidation as co"2. During the Reporting Period, there was no change in the scope consolidated financial statements of the Company.2. FINANCIAL STATEMENTS PREPARED UNDER HKGAAPCondensed consolidated income statementNotesSix months ended 30 June20102009RestatedRMB000RMB000(unaudited)(unaudited)Revenue31,352,5831,179,184Cost of sales(1,099,135)(959,486)Gross profit253,448219,698Investment income1,6412,716Other income10,7541,981Other gains and losses(820)(5,489)Distribution and selling expenses(97,732)(83,741)Administrative expenses(79,423)(74,947)Other expenses(5,494)(6,724)Share of profits of associates2,8223,823Finance costs(8,070)(7,541)Profit before tax477,12649,776Income tax expense5(13,904)(8,701)Profit for the half-year63,22241,075Profit for the half-year attributable to :Owners of the Company60,17439,115Non-controlling interests3,0481,96063,22241,075Earnings per share - basic and diluted 6RMB0.132RMB0.090Condensed consolidated statement of comprehensive incomeSix months ended 30 June20102009RMB000RMB000(unaudited)(unaudited)Profit for the half-year63,22241,075Other comprehensive income: Exchange differences arising on translation (1,266)(7) Fair value (loss) gain on available-for-sale financial assets (39,175)88,415Income tax relating to components of other comprehensive income 5,876(13,273) Other comprehensive income for the half-year, net of tax(34,565)75,135Total comprehensive income for the half-year28,657116,210Total comprehensive income attributable to:Owners of the Company26,051114,252Non-controlling interests2,6061,95828,657116,210 Condensed consolidated statement of financial positionNotes30 June 201031 December 2009RMB000RMB000(unaudited)(audited)Non-current assetsTechnical know-how-117Property, plant and equipment961,669963,747Construction in progress156,065134,356Prepaid lease payments on land use rights225,525193,915Investment properties37,03436,694Interests in associates14,18214,360Available-for-sale investments161,957201,596Deferred tax assets3,0443,0441,559,4761,547,829Current assetsInventories309,061344,220Trade and other receivables8415,289 314,353Prepaid lease payments on land use rights5,7704,070Amount due from immediate holding company6,3788,465Tax recoverable683142Pledged bank deposits74,71637,496Bank balances and cash411,529364,3981,223,4261,073,144 Assets classified as held for sale15,13315,3901,238,5591,088,534Current liabilitiesTrade and other payables9606,858491,698Amount due to an associate576498Tax payable7,9277,069Borrowings93,620124,024708,981623,289Net current assets529,578465,245Total assets less current liabilities2,089,0542,013,074Capital and reservesShare capital457,313457,313Reserves1,190,3751,164,324Proposed final dividend-22,866Equity attributable to owners of the Company1,647,6881,644,503Non-controlling interests35,43036,318Total equity1,683,1181,680,821Non-current liabilityDeferred tax liabilities5,57511,597Borrowings350,000270,000Deferred income50,36150,656405,936332,2532,089,0542,013,074 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS UNDER HKGAAP1. Basis of preparation The Groups unaudited condensed interim financial information has been prepared in accordance with the applicable disclosure provisions of Appendix 16 to the Listing Rules and with Hong Kong Accounting Standard (HKAS) 34, Interim Financial Reporting, issued by the Hong Kong Institute of Certified Public Accountants (HKICPA). The unaudited condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 31 December 2009.Principal accounting policies The consolidated condensed interim financial information has been prepared on the historical cost basis except for property, plant and equipments and certain financial instruments, which are measured at revalued amounts or fair values, as appropriate.The accounting policies used in the consolidated condensed interim financial information are consistent with those followed in the preparation of the Groups annual financial statements for the year ended 31 December 2009, except as described below.In the current year, the Group has applied, for the first time, the following new standards, amendments and interpretations (Int) (new HKFRSs) issued by the HKICPA which are effective for the Groups financial year beginning 1 January 2010.HKFRS 1 (Revised)First-time Adoption of HKFRSsHKFRS 1 (Amendment)Additional Exemptions for First-time AdoptersHKFRS 2 (Amendment)Group Cash-settled Share-based Payment TransactionsHKFRS 3 (Revised)Business CombinationsHKAS 27 (Revised) Consolidated and Separate Financial StatementsHKAS 39 (Amendment)Eligible Hedged ItemsHK(IFRIC) Int 17Distribution of Non-cash Assets to OwnersAnnual Improvements ProjectImprovements to HKFRSs 2009The Group has not early applied the following new and revised standards, amendments or interpretations that have been issued but are not yet effective.HKFRS 1 (Amendment)Limited Exemption from Comparative HKFRS 7 Disclosures for First-time Adopters2HKFRS 9 Financial Instruments5HKAS 24 (Revised)Related Party Disclosures3 HKAS 32 (Amendment)Classification of Rights Issues1HK(IFRIC) INT 14 (Amendment)Prepayments of a Minimum Funding Requirement3HK(IFRIC) INT 19Extinguishing Financial Liabilities with Equity Instruments2Annual Improvements ProjectImprovements to HKFRSs 201041 Effective for annual periods beginning on or after 1 February 2010.2 Effective for annual periods beginning on or after 1 July 2010.3 Effective for annual periods beginning on or after 1 January 2011.4 Effective for annual periods beginning on or after 1 January 2011 (unless otherwise specified).5 Effective for annual periods beginning on or after 1 January 2013.HKFRS 9 Financial Instruments introduces new requirements for the classification and measurement of financial assets and will be effective from 1 January 2013, with earlier application permitted. The standard requires all recognised financial assets that are within scope of HKAS 39 Financial Instruments: Recognition and Measurement to be measured at either amortised cost or fair value. Specially, debt investments that (i) are held within a business model whose objective is to collect the contractual cash flows and (ii) have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortised cost. All other debt investments and equity investments are measured at fair value. The application of HKFRS 9 might affect the classification and measurement of the Groups financial assets.The directors of the Company anticipate that the application of the other new and revised standards, amendments or interpretations will have no material impact on the results and financial position of the Group.3. Segment informationDescription of segmentsManagement has determined the operating segments based on the internal reports reviewed by the chief operating decision maker for the purpose of allocating resources to segments and assessing their performance. The Groups operating and reportable segments are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Chemical and other products:Production and sales of chemical and other products Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Information regarding the above segments is reported below. Segment turnover and results The following is an analysis of the Group s turnover and results by reportable segment.For the six months ended 30 June 2010Unaudited Bulk pharmaceuticalsPreparationsChemical and other products Commerce circulationsEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales740,382255,12627,769329,306-1,352,583Inter-segment sales2,034183,11990,75242,832(318,737)-Total 742,416438,245118,521372,138(318,737)1,352,583Segment profit 47,48919,9723,1165,71676,293Investment and other income12,395Other gains and losses(820)Other expenses(5,494)Finance costs(8,070)Share of profits of associates2,822Profit before tax 77,126For the six months ended 30 June 2009Unaudited Bulk pharmaceuticalsPreparationsChemical and other products Commerce circulationsEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales618,268244,6351,899314,382-1,179,184Inter-segment sales17,917163,28437,5753,881(222,657)-Total 636,185407,91939,474318,263(222,657)1,179,184Segment profit (loss)49,38613,771(1,272)(875)61,010Investment and other income 4,697Other gains and losses(5,489)Other expenses(6,724)Finance costs(7,541)Share of profits of associates3,823Profit before tax 49,776The accounting policies of the reportable segments are the same as the Groups accounting policies. Segment profit represents the profit earned by each segment without allocation of investment and other income, other gains and losses, other expenses, financial costs and share of profits of associates. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment. Inter-segment sales are charged at prevailing market rates.Segment assetsThe following is an analysis of the Group s assets by reportable segment.At 30 June 2010Unaudited Bulk pharmaceuticalsPreparationsChemical and other products Commerce circulationsTotalRMB000RMB000RMB000RMB000RMB000Segment assets1,168,819463,854321,664125,8772,080,214Unallocated corporate assets717,821Consolidated assets 2,798,035At 31 December 2009Audited Bulk pharmaceuticalsPreparationsChemical and other products Commerce circulationsTotalRMB 000RMB 000RMB 000RMB 000RMB 000Segment assets1,214,283396,322240,187112,4511,963,243Unallocated corporate assets673,120Consolidated assets2,636,363For the purposes of monitoring segment performances and allocating resources among segments: all assets are allocated to reportable segments other than deferred tax assets, interests in associates, assets classified as held for sale, available-for-sale investments, investment properties, tax recoverable, pledged bank deposits and bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments.4. Profits before taxProfit before tax has been arrived at after charging (crediting):Six months ended 30 June20102009RMB000RMB000(unaudited)(unaudited)Interest on borrowings8,0707,541Amortisation of prepaid lease payments on land use rights2,8911,511Amortisation of technical know-how117500Depreciation for property, plant and equipment58,73358,501Depreciation for investment properties1,361-Cost of inventories recognised as an expense1,099,135959,486Dividends and interest income(1,641)(2,716)(Gain) loss on disposal of property, plant and equipment(794)1,4245. Income tax expenseThe major components of income tax expense in the condensed income statement are:Six months ended 30 June20102009RMB000RMB000(unaudited)(unaudited) Current income tax PRC Enterprise Income Tax (EIT)14,0507,834Deferred income tax(146)867Income tax expense13,9048,701Under the Law of the PRC on Enterprise Income Tax (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% from 1 January 2008 onwards. Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a three-year period commencing from 2008.Pursuant to the relevant laws and regulations in the PRC, two subsidiaries operating in the PRC are entitled to exemption from the PRC income tax in the first two years from the first profit-making year, followed by a 50% reduction of the PRC income tax for the next three years.6. Earnings per shareThe calculation of the basic earnings per share is based on the Groups profit attributable to the owners of the Company of RMB60,174,000 (2009: RMB39,115,000) and based on the weighted average of 457,312,830 shares (2009 : 457,312,830 shares) in issue during the period.Basic earnings per share and diluted earnings per share for the six months ended 30 June 2010 and 2009 are the same as there were no dilutive events existed during both periods.7. Dividends(a) The board of the directors of the Company did not recommend the payment of an interim dividend for the six months ended 30 June 2010 (2009: Nil).(b) Dividends attributable to the previous financial year, approved during the interim period.Six months ended 30 June20102009RMB000RMB000(unaudited)(unaudited) Final dividend in respect of the financial year ended 31 December 2009, approved during the following interim period, of RMB0.05 per share (year ended 31 December 2008: RMB0.03 per share)22,86613,7198. Trade and other receivables30 June 201031 December 2009RMB000RMB000(unaudited)(audited) Trade and bills receivables372,321280,080Less : Allowance for doubtful debts of trade receivables(7,603)(7,603)364,718272,477Other receivables, deposits and prepayments58,40949,714-p r s t   x z ~ ιΦ}jT94h'hB*CJOJPJQJaJnHo(phtH+hbc]hCJOJPJQJaJnHo(tH%hCJOJPJQJaJnHo(tHhCJQJaJo(h5CJQJaJo( h5CJQJaJnHo(tH$h5CJPJQJaJnHo(tH(jh5CJQJUmHnHo(uh5CJQJo(h5CJOJQJh6KHOJPJQJ]h6KHOJQJ]q r s u v  x 2 X tu67$v dWD`v a$$da$^ $dT^a$$a$"H 2 X \ ` b p  H O ְwqhqhqhqhq[Lh5CJPJ\nHtHhCJPJnHo(tHh5CJ\ hCJ$hbc]hB*PJnHo(phtH,h5B*CJPJ\aJnHo(phtHh5B*CJ\aJph&hB*CJKHOJQJaJo(ph"hCJOJPJQJaJnHtH%hCJOJPJQJaJnHo(tH+h'hCJOJPJQJaJnHo(tH u{NOVW!"567UVZdh/01Uĺͳͳħͳͳͳͳͳӳͳͳӳͳ͍jhCJUhCJOJQJ^JaJ h5o( h5h#: h5CJ\hCJo(h#: h5CJh5CJ\ hCJhCJPJnHo(tHh5CJPJ\nHtHh5CJPJ\nHo(tH1fhhi01g$dWD^`a$ $d7$a$$da$UVWfgi /1IJKlmn^bfghi{h5CJ\*h0J.>*B*CJOJQJ^JaJphh0J.B*CJphjhCJUjhCJUhCJOJQJ^JaJhCJPJnHo(tHhCJo( hCJjhCJUjhCJU. 24DFNP~@BHJβrhCJPJaJnHo(tHh5CJaJo(h5CJaJ h5CJPJaJnHo(tH h5 h5o(%hCJOJPJQJaJnHo(tHh5CJ\hCJo(hCJPJnHo(tH hCJjhCJUjhCJU'34EFOP@BXl $$1$Ifa$$da$"$&024@BJLRTXl8FQϾϳϟϳςteϾT!hOCJKHPJaJnHo(tHhCJKHOJQJaJo(hCJKHOJQJaJh5CJKHOJQJaJh5CJKH\aJo('h5CJKHPJ\aJnHo(tHhCJKHaJo(!hCJKHPJaJnHo(tHhCJKHaJ,h5CJKHOJPJQJaJnHo(tHh5CJKHOJQJaJ ~ppp$$1$Ifa$gd $1$Ifxkd$$Ifl\ (#  p(#644 lalRcty~ppp$$1$Ifa$gd $1$Ifxkd"$$Ifl\ (#  p(#644 lalQRcxyz <=>CDIJUvk]I]'h5CJKHPJ\aJnHo(tHh5CJKH\aJo(hCJKHaJo(,h5CJKHOJPJQJaJnHo(tHh5CJKHOJQJaJ!hOCJKHPJaJnHo(tH!hCJKHPJaJnHo(tHhB*CJaJphhCJKHOJQJaJo(hCJKHOJQJaJh5CJKHOJQJaJhCJKHaJyzxjjj$$1$Ifa$gd -00$IfXDYDxkd$$Ifl\ (#  p(#644 lal~ppp$$1$Ifa$gd $1$Ifxkdr$$Ifl\ (#  p(#644 lal \h~sssss $$1$Ifa$$1$Ifxkd$$Ifl\ (#  p(#644 lalUVYZ\h (6DJRftӹӑtӂtӂtӑcӂtӑc!hfCJKHPJaJnHo(tHhCJKHOJQJaJh5CJKHOJQJaJ!hCJKHPJaJnHo(tH,h5CJKHOJPJQJaJnHo(tHh5CJKHOJQJaJhCJKHaJo(hCJKHaJh5CJKH\aJo('h5CJKHPJ\aJnHo(tH&~ppp$$1$Ifa$gd $1$Ifxkd$$Ifl\ (#  p(#644 lal ~ppp$$1$Ifa$gd $1$Ifxkd^$$Ifl\ (#  p(#644 lal(6DJ~ppp$$1$Ifa$gd $1$Ifxkd$$Ifl\ (#  p(#644 lalJK~ppp$$1$Ifa$gd $1$Ifxkd$$Ifl\ (#  p(#644 lal~ppp$$1$Ifa$gd $1$IfxkdV $$Ifl\ (#  p(#644 lal./49?[\afl!"(-345ͼͼ墔|eeͼVhCJPJaJnHo(tH,h5CJKHOJPJQJaJnHo(tH/hZhCJKHOJPJQJaJnHo(tHhZCJKHOJQJaJ2hZh5CJKHOJPJQJaJnHo(tH!hCJKHPJaJnHo(tHhCJKHaJhCJKHOJQJaJh5CJKHOJQJaJhCJKHaJo(!/49?~ppp$$1$Ifa$gd $1$Ifxkd $$Ifl\ (#  p(#644 lal?@\afl~ppp$$1$Ifa$gd $1$Ifxkd $$Ifl\ (#  p(#644 lallm~ppa$$1$4$Ifa$gd $$1$Ifa$gd $1$IfxkdN $$Ifl\ (#  p(#644 lal~ppp$$1$Ifa$gd $1$Ifxkd $$Ifl\ (#  p(#644 lal"(-3~ppp$$1$Ifa$gd $1$Ifxkd $$Ifl\ (#  p(#644 lal345;X]jzzlY-$00$4$IfXDYDa$-00$IfXDYD -00XDYDxkdF$$Ifl\ (#  p(#644 lal5X\]jk[cd0:@OPjvwѱѠэѱѱэ…ѱ…w…hCJKHaJnHtHhCJaJ$hCJPJhmH nHo(sH tH!hCJPJhmH nHsH tH hCJhmH nHo(sH tHh5CJKHOJQJaJhCJhmH nHsH tHhh5B*CJ\aJphhB*CJaJph)jk;SkdS$$Ifl0u"w t644 la$$1$Ifa$gd w00$IfXDYDSkd$$Ifl0u"w t644 la@O;Skd$$Ifl0u"w t644 la$$1$Ifa$gd w00$IfXDYDSkd$$Ifl0u"w t644 laOPjvw9Skd$$Ifl0u"w t644 la$$1$Ifa$gd w00$IfXDYDUkd$$Ifl\0u"w t644 laCA9$da$Skd$$Ifl0u"w t644 la$$1$Ifa$gd $IfSkdP$$Ifl0u"w t644 la  : > R V ϾxfVE!hCJKHPJaJnHo(tHhCJKHOJQJ^JaJ"hCJKHOJPJQJnHtHhCJKHOJQJo(%hCJKHOJPJQJnHo(tH,h5CJKHOJPJQJaJnHo(tHh5CJKHOJQJaJ h5CJKHOJQJaJo(hCJo( hCJh5CJaJo(h5CJaJhCJPJaJnHo(tH V ykk$$1$Ifa$gd ekd$$Ifl,F3 EW 6    44 la $$Ifa$$If $$Ifa$$da$ !!! !,!.!0!T!V!f!h!v!x!z!!!!!!!!""""0"̻̻̻̻rdrS!hCJKHPJaJnHo(tHhlIhCJKHaJo('hlIhCJKHPJaJnHo(tHhCJKHaJhCJKHaJo(hCJKHOJQJ^JaJhCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo(!h5CJKHOJQJ^JaJ$h5CJKHOJQJ^JaJo(hCJKHPJaJnHtH ! !.!$$1$Ifa$gd $Ifekd$$Ifl,F3 EW 6    44 la.!0!V!h!x!$$1$Ifa$gd $Ifekd$$Ifl,F3 EW 6    44 lax!z!!!!$$1$Ifa$gd $Ifekdj$$Ifl,F3 EW 6    44 la!!2"@"N"yy$$1$Ifa$gd $IfVDKWDY^`ekd$$Ifl,F3 EW 6    44 la0"2">"@"L"N"P""""""""""""##ппvkWF7h5CJKHOJQJaJ h5CJKHOJQJaJo(&hB*CJPJaJnHo(phtHh5CJaJo( h5CJPJaJnHo(tHh5CJaJhCJPJaJnHo(tHhCJKHOJQJ^JaJhCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo(!h5CJKHOJQJ^JaJ$h5CJKHOJQJ^JaJo(hCJKHaJo(N"P""""$$1$Ifa$gd $IfVDx^ekdJ$$Ifl,F3 EW 6    44 la"""""#B#p##[RIII $$Ifa$ $$Ifa$%<TPL HD@< ^$da$TQ ekd$$Ifl,F3 EW 6    44 la#&#*#>#@#B#l#p#############붩|kXkXkG7hCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo($h5CJKHOJQJ^JaJo(!h5CJKHOJQJ^JaJhCJKHaJhCJKHaJo( hQJ"hCJKHOJPJQJnHtHhCJKHOJQJo(%hCJKHOJPJQJnHo(tH%h5CJKHOJPJQJnHtHh5CJKHOJQJo((h5CJKHOJPJQJnHo(tH#####$$1$Ifa$gd $If`kd*$$IflF '!@ @  t!    4 la###$$$$1$Ifa$gd $If`kd$$IflF '!@ @  t!    4 la###$$$$$$*$2$3$;$<$=$T$Z$[$]$i$j$t$u$$$$$$ڶڶscڶTKh5CJaJhCJPJaJnHo(tHhCJKHPJaJnHtHhlIhCJKHaJo('hlIhCJKHPJaJnHo(tH!hCJKHPJaJnHo(tHhCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo($h5CJKHOJQJ^JaJo(!h5CJKHOJQJ^JaJhCJKHaJo(hOJQJaJ$$*$3$<$$$1$Ifa$gd $If`kd$$IflF '!@ @  t!    4 la<$=$j$u$$$$1$Ifa$gd $If`kd$$IflF '!@ @  t!    4 la$$$$$$0%g% $$Ifa$$da$`kd$$IflF '!@ @  t!    4 la$$$$$%%$%/%0%M%[%f%i%%%%%%%%%%%%%%%ijzzzll^M!hCJKHOJQJ^JaJo(hCJPJaJnHtHhCJPJaJnHtHhCJaJo(hCJPJaJnHo(tHhCJOJQJaJnHtH!hnzCJKHPJaJnHo(tH!hCJKHPJaJnHo(tHhCJKHaJhCJOJQJaJo(hCJaJo( h5CJPJaJnHo(tHh5CJaJo(g%h%i%~%%%% $$Ifa$$If`kdi$$If4F H&<<d&    4 af4%%%%%&&vpbbbb$$1$Ifa$gd$Ifkd$$If4rn H&d&4 af4%%%%%&&&&:&G&H&U&V&f&g&w&x&y&&&&&&&&&&&&&'' ','-'<'='L'M'N'k'w'x'''''''''''''(((((&(P(R(^(_(hCJPJaJnHo(tHhCJOJQJaJhCJPJaJnHtHhCJOJQJaJnHtH!hCJKHOJQJ^JaJo(hCJKHOJQJ^JaJA&&:&H&V&g&x&{ugggg$$1$Ifa$gd$Ifkd$$Ifrn H&d&4 ax&y&&&&{r:4$If7kd$$IfH&d&d&4 a $$Ifa$kd $$Ifrn H&d&4 a&&&&&&' '-'='M'mg$Ifkd$$Ifrn H&d&4 a$$1$Ifa$gd M'N'k'x''''{ugggg$$1$Ifa$gd$Ifkd{$$Ifrn H&d&4 a'''''(({ugggg$$1$Ifa$gd$Ifkd$$Ifrn H&d&4 a((R(_(p((({ugggg$$1$Ifa$gd$Ifkd$$Ifrn H&d&4 a_(o(p((((((((((()))))) )!)b)d))))))))*5*M*N*O*P*V*********X+Y+үuhCJaJnHtHhCJaJhCJaJo(hCJPJaJnHo(tHhCJPJaJnHtH)hCJOJPJQJ^JaJnHo(tHhCJPJaJnHtHhCJOJQJaJhCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo(.((((()){ugggg$$1$Ifa$gd$Ifkd$$Ifrn H&d&4 a)))b)c)**++z,,,{yttktkkkkc$da$ $7$8$H$a$$a$kd$$Ifrn H&d&4 a Y+++++%,1,n,x,z,~,,,,,,,,,,,,,,,,ͱwhXJh5B*CJaJphhB*CJOJQJaJphhCJPJaJnHo(tHh5CJaJo(h5CJaJ3h5CJKHOJPJQJ\^JaJnHo(tH h5o( h5%hCJOJQJ^JaJnHo(tHhnHo(tHhnHtHhCJPJaJnHtHhCJaJnHo(tHhCJPJaJnHo(tH,,,,,, - --h[$$If^a$okd7$$IfTl4TF "$  t1%6    44 laf4T$$If^a$ $If^$da$7$8$H$,,- - --[-\-------... .(.).Y.r.s.z....... ///0/Z/~//////00Ҿwlh5CJaJo(h5CJaJhCJPJaJnHo(tHhmHnHo(tHhOJQJ^JhhOJQJ^JnHtHhCJaJ ho(h5B*CJaJo(phhOJQJaJh5B*CJaJph)h5B*CJPJaJnHo(phtH)-&-5-R-k-----\SG $d$Ifa$ !$$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T$$If^a$---------.]T !$$Ifa$kdu$$IfTl4Tr ""$  t1%644 laf4T $d$Ifa$ .. .".$.&.(.i`TTTT $d$Ifa$ !$$Ifa$kd0$$IfTl4Tr ""$  t1%644 laf4T(.).Y.`.f.m.r.i^RRRR $d$Ifa$ !$$G$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4Tr.s.z.|.~...i`TTTT $d$Ifa$ !$$Ifa$kd$$IfTl4Tr ""$  t1%644 laf4T.......i`TTTT $d$Ifa$ !$$Ifa$kda $$IfTl4Tr ""$  t1%644 laf4T.. ///)///i`TTTT $d$Ifa$ !$$Ifa$kd!$$IfTl4r ""$  t1%644 laf4T//0/Z/f/l/x/~/i`TTTT $d$Ifa$ !$$Ifa$kd!$$IfTl4Tr ""$  t1%644 laf4T~///////i`TTTT $d$Ifa$ !$$Ifa$kd"$$IfTl4Tr ""$  t1%644 laf4T///0 00e001W1ig_]TTTTT $$Ifa$$da$kdM#$$IfTl4Tr ""$  t1%644 laf4T 0 00001W1X11111111111112L2W2222222222u3334W4X44545Z55ιΎιήιιnn&h9h5CJPJaJnHo(tHh9h5CJaJhKHPJmH nHtHu!hCJPJ^JaJnHo(tHhCJ^JaJo(hCJ^JaJh5CJ\aJhCJaJ h5CJPJaJnHo(tHh5CJaJhCJPJaJnHo(tH*W1b111111LF== $$Ifa$$Ifkd$$$If֞| ,l$|4|%4 a $$Ifa$111222L2?9$Ifkd$$$If֞| ,l$|4|%4 a !d$1$If $$Ifa$L2W2a2m2x22222Fkd%$$If֞| ,l$|4|%4 a$If $$Ifa$2222363D3E3u3Fkd&$$If֞| ,l$|4|%4 a$If $$Ifa$u3333333$If $dh$Ifa$ $$Ifa$3334 444G4U4UOFFFFOF $$Ifa$$Ifkdf'$$If֞| ,l$|4|%4 aU4V4W4X4m445[55USSJJJJJ $$Ifa$kd?($$If֞| ,l$|4|%4 a555566)8*8.828i8l8888&9h9i999999999994:5:u:v:::2;3;r;s;;;;;;6<7<q<r<<<<<<<<<5=6=u=v=========չ hCJhCJo(hCJPJnHo(tHhCJPJaJnHo(tHhCJaJh5CJaJh9h5CJaJh9h5CJaJo(B5555555LF== $$Ifa$$Ifkd)$$If֞| ,l$|4|%4 a $$Ifa$555666J6Fkd)$$If֞| ,l$|4|%4 a$If $$Ifa$J6U6`6b6d666$If $$Ifa$ $dh$Ifa$6666666UOCC:: $$Ifa$ $dh$Ifa$$Ifkd*$$If֞| ,l$|4|%4 a67&7'7W7a7k7OCC $dh$Ifa$kd+$$If֞| ,l$|4|%4 a$Ifk7m7o77777Fkdd,$$If֞| ,l$|4|%4 a$If $$Ifa$777778(8$If $$Ifa$ $dh$Ifa$(8)8*8;;==#>$>UMMMMKMK$da$kd7-$$If֞| ,l$|4|%4 a===============>> > >>">#>$>7>9>w>x>y>>>>>>>k?˳֤~oaoaoh5B*CJaJphh5B*CJaJo(ph"hB*CJOJQJaJo(ph&hB*CJPJaJnHo(phtHhCJPJaJnHo(tH/h5CJOJPJQJ\^JaJnHo(tHh5CJaJo( h5CJPJaJnHo(tHh5CJaJhCJPJaJnHo(tH"$>x>y>>>>>?G?p?$$If^a$^$da$ k?o?p?q??????????????????????#@A@K@L@P@Q@R@S@]@^@_@@@@@@@@@@@@ AAȷzȷzȷzȖzhxCJaJhxh~K\hxCJKHOJaJo(h~K\hxCJKHOJaJ#h~K\hxCJKHOJQJaJo( h~K\hxCJKHOJQJaJhxCJKHaJh&h5B*CJPJaJnHphtH)h5B*CJPJaJnHo(phtH0p?q?w????k\DD/$d$1$7$8$H$Ifa$gdWX$d$1$4$7$8$H$Ifa$d$1$7$8$H$Ifkd .$$IfTֈ ~4 T$ p T$aT???????VG5$d$1$7$8$H$Ifa$d$1$7$8$H$Ifkd.$$IfTֈ ~4 T$ p T$aT$d$1$7$8$H$Ifa$gdWX?????$d$1$7$8$H$Ifa$gdWX??#@$d$1$7$8$H$Ifkd/$$IfTֈ ~4 T$ p  <T$ap<T#@A@L@Q@S@^@$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$^@_@@$Xd$1$7$8$H$Ifkd0$$IfTֈ ~4 T$ p  <T$ap<T@@@@@@$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$@@ A$ $7$8$H$Ifkd2$$IfTֈ ~4 T$ p  <T$ap<T AAAA A"A$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$AAAAAA A!A"A#ASAqAzA{AAAAAAAAAAAAAAAAAAAAB B BBBBBBBB/BCBDBMBNBRBSBTBUBVBWBXBBBBBBBBBBBB¾¾¾¾¾¾hxCJKHaJhxCJaJhxh~K\hxCJKHOJaJo(h~K\hxCJKHOJaJh=ythxCJKHOJaJo(h=ythxCJKHOJaJA"A#ASA$d$1$7$8$H$Ifkdf3$$IfTֈ ~4 T$ p  <T$ap<TSAqA{AAAA$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$AAA$d$1$7$8$H$Ifkd4$$IfTֈ ~4 T$ p  <T$ap<TAAAAAA$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$AAA$d$1$7$8$H$Ifkd5$$IfTֈ ~4 T$ p  <T$ap<TAB BBBB$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$BB/B$d$1$7$8$H$IfkdJ7$$IfTֈ ~4 T$ p  <T$ap<T/BDBNBSBUBWB$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$WBXBB$d$1$7$8$H$Ifkd8$$IfTֈ ~4 T$ p  <T$ap<TBBBBBB$d$1$7$8$H$Ifa$gdWX$d$1$7$8$H$Ifa$BBB$"kd9$$IfTֈ ~4 T$ p  <T$ap<TBBBB5C6CUCVCWCjCCCCCCCCCC+D6D?D@DoDyDDDDDDDEE$E%E0E:ECEDErE|EEEEEEE!F*F2F3F4F5F𽮥hOJQJhCJaJhCJKHaJh5OJQJh5B*CJaJo(phh5B*CJaJphh5CJaJo( h5CJPJaJnHo(tHh5CJaJhCJPJaJnHo(tH4BVCWCkCCCCCCC~l^$d,$4$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd.;$$IflFP" "    4 la $If^$da$ CCCCCt $d,$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd;$$IflFP" "    4 laCC+D6D?Dt $d,$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd<$$IflFP" "    4 la?D@DoDyDDt $d,$Ifa$$d$1$7$8$H$Ifa$"d$1$7$8$H$If]kd<$$IflFP" "    4 laDDDDDx $d,$Ifa$$d$1$7$8$H$Ifa$ $7$8$H$If]kd=$$IflFP" "    4 laDDEE$Et $d,$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd=$$IflFP" "    4 la$E%E0E:ECEt $d,$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd >$$IflFP" "    4 laCEDErE|EEt $d,$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd>$$IflFP" "    4 laEEEEEr$d,$4$Ifa$$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd?$$IflFP" "    4 laEE"F*F3F$d$1$7$8$H$Ifa$d$1$7$8$H$If]kd{?$$IflFP" "    4 la3F4F5F;FN?NXNaNrNuN|NNNNNNNNNNNNNNNNسyygyWghB*CJOJQJaJph"hB*CJOJQJaJo(phhOJQJ)h5B*CJPJaJnHo(phtHh5B*CJaJphh5B*CJaJo(ph"hB*CJOJQJaJo(phhCJPJnHo(tH hCJhCJo(3h5CJKHOJPJQJ\^JaJnHo(tH h5o("M9N:N?NHNuNNNNN_R$$If^a$kdq@$$Iflr3z"6m t64 la $If^^$da$ NNNNNNNNNNN`kd!A$$Iflr3z"6m t64 la $If^$$If^a$ NNNNNNNwjj``` $If^$$If^a$kdA$$Iflr3z"6m t64 laNNNNNNNNNNNNNNOOO#O&O'O+O,O:O;OOOPO_OdOgOhOlOmO}O~OOOOOOOOOOOPPPPPP)P?P\PůݯݯݯݯhOJQJnHtHhOJQJ(hYh5B*CJOJQJaJph+hYh5B*CJOJQJaJo(ph.hB*CJOJPJQJaJnHo(phtH"hB*CJOJQJaJo(phhB*CJOJQJaJph4NNOO#O'O+Owjj``` $If^$$If^a$kduB$$Iflr3z"6m t64 la+O,O;OPO`OdOhOlOwjjj``` $If^$$If^a$kdC$$Iflr3z"6m t64 lalOmO~OOOOOOOwjjjj``` $If^$$If^a$kdC$$Iflr3z"6m t64 laOOOPPPPwjj``` $If^$$If^a$kdsD$$Iflr3z"6m t64 laPP)P\P`PdPhPwjj``` $If^$$If^a$kdE$$Iflr3z"6m t64 la\P`PcPdPhPiPvPPPPPPPPPPPPPPPPPPPQQQQQQ5QXQ\Q_Q`QdQeQiQjQkQwQ{Q|Q}QQQQQQQQQQQQQQQQQQ֤֤֤֤֤hOJQJhB*CJOJQJaJphhOJQJnHtH+hYh5B*CJOJQJaJo(ph.hB*CJOJPJQJaJnHo(phtH"hB*CJOJQJaJo(ph=hPiPvPPPPPwjj``` $If^$$If^a$kdE$$Iflr3z"6m t64 laPPPPPPPwjj``` $If^$$If^a$kdqF$$Iflr3z"6m t64 laPPPQQQQwjj``` $If^$$If^a$kdG$$Iflr3z"6m t64 laQQ5QXQ\Q`QdQwjj``` $If^$$If^a$kdG$$Iflr3z"6m t64 ladQeQfQgQhQiQjQwjj``` $If^$$If^a$kdoH$$Iflr3z"6m t64 lajQkQxQyQzQ{Q|Qwjj``` $If^$$If^a$kdI$$Iflr3z"6m t64 la|Q}QQQQQQwjj``` $If^$$If^a$kdI$$Iflr3z"6m t64 laQQQQQQRwjj``` $If^$$If^a$kdmJ$$Iflr3z"6m t64 laQRRRRR"R%R&R,R-R>R?RURZR]R^RbRcRrRsRRRRRRRRRRRRRRRRRRRRRRRRRSSSSSS S*S@SFSѿѿѿѿѿѿᙊѿѿѧѿῧѿh5B*CJaJo(phh5B*CJaJph.hB*CJOJPJQJaJnHo(phtH"hB*CJOJQJaJo(phhB*CJOJQJaJphhOJQJ+hYh5B*CJOJQJaJo(ph6RRRR"R&R,Rwjj``` $If^$$If^a$kdK$$Iflr3z"6m t64 la,R-R?RVRZR^RbRwjj``` $If^$$If^a$kdK$$Iflr3z"6m t64 labRcRsRRRRRwjj``` $If^$$If^a$kdkL$$Iflr3z"6m t64 laRRRRRRRwjj`S`$$If^a$ $If^$$If^a$kdM$$Iflr3z"6m t64 laRRRRRRRwjj`S`$$If^a$ $If^$$If^a$kdM$$Iflr3z"6m t64 laRRRRRRRwjj``` $If^$$If^a$kdiN$$Iflr3z"6m t64 laRRRSSSSwjj``` $If^$$If^a$kdO$$Iflr3z"6m t64 laSS*SBSFSJSNSwjj``` $If^$$If^a$kdO$$Iflr3z"6m t64 laFSISJSNSOS]SsSyS|S}SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS֤֤֤ֈ֤yhCJPJaJnHo(tH7hYh5B*CJOJPJQJaJnHo(phtHhB*CJOJQJaJphhOJQJnHtH+hYh5B*CJOJQJaJo(ph"hB*CJOJQJaJo(ph.hB*CJOJPJQJaJnHo(phtH.NSOS]SuSyS}SSwjj``` $If^$$If^a$kdgP$$Iflr3z"6m t64 laSSSSSSSwjj``` $If^$$If^a$kdQ$$Iflr3z"6m t64 laSSSSSSSwjj``` $If^$$If^a$kdQ$$Iflr3z"6m t64 laSSSSSSSwjj``` $If^$$If^a$kdeR$$Iflr3z"6m t64 laSSSTUXXXXoYpY*Z+Zwummmummmmmu$da$kdS$$Iflr3z"6m t64 la S T!T0T1T7T8TFTGTMTTUUU U!U-U.U_U`UkUmUoUtUuU~UUUUUUUUVV^V_VuVvVVV&W'WWWWW\?\C\G\^\d\e\g\w\z\\\\\\\\\\\\\\\\ֽ֗}pipip}ppipppphCJo(hCJPJnHo(tHhPJQJnHo(tHhQJo( hCJhB*CJph!hCJPJQJaJnHo(tHhCJQJaJo(hCJQJaJhCJPJaJnHo(tHhCJaJh9CJPJaJnHo(tH#hjh9CJPJaJnHo(tH)\%]&]7]9]]]]]]]]]]]]]^^G^I^d^g^^^^^_ _ _ ___B_I_W___h_j_______` `<`>`C`E```j```aaa!aaaaaaaò h^}CJ h5CJPJaJnHo(tHh5CJaJh5CJaJo(hCJPJaJnHo(tHhCJPJnHo(tHhCJo( hCJ@aaa b'b0b2b3b^b_b{bbbbbbbbbbbbbccc=cGcncoccccccccccccccc d$dpdudddeeeeff&flf~ggggggggggnhqhhhhhhhhhiiFiKiPiYiihCJPJnHo(tH hCJhCJo(hjhCJhjh^}CJTiijj%j4jJjRjejgjjjqjxjyjjjjjjjjjjjjjjjjjjkk kkkUk[kkkkkkkllllBlQl`lel~llllllllll!m"m*m,m9mFmmmnmtmxmmmmmmmmmmmmmmh<CJPJnHo(tHhCJPJnHo(tH hCJhCJo(Tjjjjllmmmnnnooooiqjqkqqqqtt0t1tvvv$da$mm#n(nXn`nansnnnnnnnnnnnn o:oBoToUoVo]obotoooooooooooop"p$pLpTpppqq,qDLNtg^UUUUJ $$4$Ifa$ $$Ifa$ $$Ifa$kdTa$$Iflֈh  ^"9U{!64 latuvYg[[[[[[SS$da$ $da$kdb$$Iflֈh  ^"9U{!64 la ѡ07hnޢߢXYZuvw egstuĥť$%9:no03»h5CJaJo(h5CJaJ#h5CJPJ\aJnHo(tH h5o( h5%hCJOJPJQJaJnHo(tHhCJPJnHtHhCJo(hCJPJnHo(tH hCJ:YZvwfgtu12רبAB $7$8$H$a$ ^`$da$ʧ&*TUkor֨6dmu/FNr @B+,lmݯ9<WXstհװްORgipu~hCJPJnHtHhCJo( hCJhCJPJnHo(tHVְװPQhi56qr}Ҳ Wjw $$1$Ifa$7$8$H$$da$߱ $-.4:pqr|}ѲҲ  56?BVWjwx~λxhxhCJKHOJQJ^JaJ!hCJKHOJQJ^JaJo(hCJKH0h5CJKHOJPJQJ^JaJnHo(tH!h5CJKHOJQJ^JaJ$h5CJKHOJQJ^JaJo(-hCJKHOJ PJQJ ^J aJnHo(tHhCJPJnHo(tH hCJhCJo((wx)!!$1$Ifkdb$$Ifl %<j JG' %F1pq($$$$44 laʳ˳ EFstz{#$()*g.0169;=>uw^_ļļļļ hCJhCJo(-hCJKHOJ PJQJ ^J aJnHo(tH!hCJKHOJQJ^JaJo(hCJKH%hCJOJPJQJaJnHo(tHhCJOJQJaJo(hCJOJQJaJhCJKHOJQJ^JaJ5˳ $$Ifa$ )!!$1$Ifkdc$$IflY %<j JG' %F1pq($$$$44 la +6Fjs $$Ifa$st{)!!$1$Ifkd4e$$IflY %<j JG' %F1pq($$$$44 laִ $$4$Ifa$ $$Ifa$) $$1$Ifa$kdkf$$IflY %<j JG' %F1pq($$$$44 la $&( $$Ifa$()*fg=<6...$da$7$8$H$kdg$$IflYִ%<j JG' %wpq(    44 la=>HIXk|ʹ $If^7$8$H$$da$'(MPڸܸHIWXjk{|ɹʹ˹OPQ{ѺҺӺԺοzun h5o( h5hKHPJnHo(tHhCJaJhCJ^JaJo(hCJaJo(hCJOJQJnHtHh5B*CJaJphh5B*CJaJo(ph-hCJKHOJ PJQJ ^J aJnHo(tHhCJPJnHo(tH hCJhCJo(+ʹ˹׹Puooooo$Ifkdh$$IflrP +!mn| /"644 laPQ]{Һuooooo$IfkdPi$$IflrP +!mn| /"644 laҺӺԺ+,BCSTuogogogogog$da$7$8$H$kdi$$IflrP +!mn| /"644 la *+,ACUXBCRST`fklqrzüļHI̽ͽ˻ˮĮėčth.ohCJPJnHo(tHh.ohCJhB*CJph-hCJKHOJ PJQJ ^J aJnHo(tHhCJPJnHo(tHh5CJ\hCJo( hCJ3h5CJKHOJPJQJ\^JaJnHo(tHh5CJaJo(h5CJaJ-ľžLM]^*,> $$1$Ifa$$7$8$H$]a$ ^` $da$gdo}_7$8$H$$da$ͽrsþľžBFklEJno<=KLMTYbcƻƻƻ{{hPJnHo(tHh-hCJKHOJ PJQJ ^J aJnHo(tH3h5CJKHOJPJQJ\^JaJnHo(tHh5CJaJo(h5CJaJ-hCJKHOJ PJQJ ^J aJnHo(tHhCJo(hCJPJnHo(tH hCJ/$."<]*,:<žhaTNa hCJhCJPJnHo(tHhCJo(.h5;@KHOJPJQJ\nHo(tH h5CJPJaJnHo(tHh5CJaJo(h5CJaJ&h5;CJPJ\aJnHo(tH h5 h5o(ho}_ho(ho}_ho}_o(ho}_CJo( h.ohh.oho(hPJnHo(tHh ho( "$<>Z\tv NP ɴrr]RH]RHhCJKHaJh5CJKHaJ)hCJKHOJPJQJaJnHo(tHhCJKHPJaJnHtHhCJKHOJQJhCJKHaJhCJKHaJo(!hCJKHPJaJnHo(tH)h5CJKHOJPJQJaJnHtH,h5CJKHOJPJQJaJnHo(tHh5CJKHOJQJaJ h5CJKHOJQJaJo( $>\v $$1$Ifa$$1$Ifekdj$$IflF"&J &&J%6    44 la5 0Nsk```` $$1$Ifa$$1$Ifkdk$$Iflr>"&J &&&&%644 la5NPsaVVVV $$1$Ifa$L$1$IfWD^L`kdk$$Iflr>"&J &&&&%644 la5 !3CUdsk```` $$1$Ifa$$1$Ifkd>l$$Iflr>"&J &&&&%644 la5 !Cde-.Lij)*89]qr56AB%&DaɽɽɽɽɽɽɽɽɽɽɽhCJKHaJo(hCJKHOJQJhCJKHaJh5CJKHaJhCJKHPJaJnHtH!hCJKHPJaJnHo(tH@desk```` $$1$Ifa$$1$Ifkdl$$Iflr>"&J &&&&%644 la5sk```` $$1$Ifa$$1$Ifkdfm$$Iflr>"&J &&&&%644 la5.=L[isk```` $$1$Ifa$$1$Ifkdm$$Iflr>"&J &&&&%644 la5ijsk]RRRR $$1$Ifa$ $1$IfWD` $1$Ifkdn$$Iflr>"&J &&&&%644 la5saVVVV $$1$Ifa$ $1$IfWDp^ `kd"o$$Iflr>"&J &&&&%644 la59K]oqsk```` $$1$Ifa$$1$Ifkdo$$Iflr>"&J &&&&%644 la5qrsaVVVV $$1$Ifa$ $1$IfWDp^ `kdJp$$Iflr>"&J &&&&%644 la5 (5sk```` $$1$Ifa$$1$Ifkdp$$Iflr>"&J &&&&%644 la556saVVVV $$1$Ifa$ $1$IfWDp^ `kdrq$$Iflr>"&J &&&&%644 la5smbbbb $$1$Ifa$$Ifkdr$$Iflr>"J &&&&%644 la5&5DSask```` $$1$Ifa$$1$Ifkdr$$Iflr>"&J &&&&%644 la5ab~saVVVV $$1$Ifa$D$1$IfWD^`Dkd.s$$Iflr>"&J &&&&%644 la5ab}~=>Vqr56Tqr{|4DEZĺĺߣĺĺĺĺߣߒĺĺυąh5CJKHQJaJ!h.oCJKHPJaJnHo(tHhCJKHaJo(hCJKHOJQJhCJKHaJh5CJKHaJhCJKHPJaJnHtH!hCJKHPJaJnHo(tHhCJKHOJQJnHtH4saVVVV $$1$Ifa$ $1$IfWDp^ `kds$$Iflr>"&J &&&&%644 la5>JVdqsaVVVV $$1$Ifa$ $1$IfWD^` kdVt$$Iflr>"&J &&&&%644 la5qrsk```` $$1$Ifa$$1$Ifkdt$$Iflr>"&J &&&&%644 la5sk```` $$1$Ifa$$1$Ifkd~u$$Iflr>"&J &&&&%644 la56ETcqsk```` $$1$Ifa$$1$Ifkdv$$Iflr>"&J &&&&%644 la5qrsaVVVV $$1$Ifa$$1$IfWD ^`kdv$$Iflr>"&J &&&&%644 la5"4BDsk```` $$1$Ifa$$1$Ifkd:w$$Iflr>"&J &&&&%644 la5DE[ sk```` $$1$Ifa$$1$Ifkdw$$Iflr>"&J &&&&%644 la5 JLdz|&f,-hv1QRST[\ννννννΑwkhCJaJnHtHh5CJaJ!h56PJ\]nHo(tHhPJnHo(tH!h.oCJKHPJaJnHo(tHhCJKHPJaJnHtH!hCJKHPJaJnHo(tHhCJKHOJQJnHtHhCJKHaJhCJKHQJaJh5CJKHaJ$LXdpzsaVVVV $$1$Ifa$ $1$IfWD^` kdbx$$Iflr>"&J &&&&%644 la5z|saVVVV $$1$Ifa$ $1$IfWD^` kdx$$Iflr>"&J &&&&%644 la5&FfsaVVVV $$1$Ifa$ $1$IfWD^` kdy$$Iflr>"&J &&&&%644 la5,saVVVV $$1$Ifa$ $1$IfWD^` kdz$$Iflr>"&J &&&&%644 la5,-saVVVV $$1$Ifa$ $1$IfWD^` kdz$$Iflr>"&J &&&&%644 la51?QsaVVVV $$1$Ifa$ $1$IfWD^` kdF{$$Iflr>"&J &&&&%644 la5QRST[\sqg_q___q_$da$ T^kd{$$Iflr>"&J &&&&%644 la5 \]125Rijms|tdhCJOJPJQJnHtHhCJaJh5CJaJo(h5CJo(hCJaJ h5CJPJaJnHo(tHh5CJaJhCJPJaJnHo(tHhCJPJnHo(tHhCJo( hCJhCJfHq &'jhCJUfHq &! ^MZd$If^Z`]kdn|$$IfFrp#n0 .$    4 a%$!d$4$Ifa$%$!d$Ifa$d$If^`d$da$#&)+,./89:;KL[dfgklstvhCJPJaJnHo(tHhCJo(h>*CJhCJaJhCJPJnHo(tH hCJh>*CJaJ h>*CJOJQJnHo(tH!hCJOJPJQJnHo(tHh>*CJOJQJ!hCJOJPJQJnHo(tH2 !&+,-./8vePP$d$&dIfPa$Zd$If^Z`pkd|$$If\rp#n.$4 a $d$Ifa$ $d$Ifa$89:;CK}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd~}$$If\rp#n.$4 aKLMNZf}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd ~$$If\rp#n.$4 afghijk}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd~$$If\rp#n.$4 akltv}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd"$$If\rp#n.$4 a}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd:$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdƀ$$If\rp#n.$4 a}qeW$d$4$Ifa$ $d$Ifa$ $d$Ifa$Zd$If^Z`pkdR$$If\rp#n.$4 a }qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdށ$$If\rp#n.$4 a')78JYZ[deklmn  !(/0BCDENOTUVWYh= CJPJnHo(tH *hCJhCJPJaJnHo(tHhCJPJnHo(tHhCJo( hCJhCJaJJ()/7}qeW$d$4$Ifa$ $d$Ifa$ $d$Ifa$Zd$If^Z`pkdj$$If\rp#n.$4 a78Z[dm}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 amn}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkd&$$If\rp#n.$4 a }qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a !(/}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd>$$If\rp#n.$4 a/0CENV}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkdʆ$$If\rp#n.$4 aVWXYZ[}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdV$$If\rp#n.$4 aYZ[\ktu}  !"<=IJLOQ֊zhCJOJPJQJnHtH!hCJOJPJQJnHo(tHhCJPJaJnHo(tH h5CJPJaJnHo(tHhB*CJph!hCJOJPJQJnHo(tHhCJo(hCJPJnHo(tHhCJaJ hCJ *hCJ0[\uv}{oZZ$d$&dIfPa$ $d$Ifa$Xd$IfWD^X`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdn$$If\rp#n.$4 a{occ $d$Ifa$ $d$Ifa$Zd$If^Z`rkd$$IfG\rp#n.$4 asgg $d$Ifa$ $d$Ifa$d$IfVDG^pkd$$If\rp#n.$4 as^^$d$&dIfPa$ $d$Ifa$d$IfVDG^pkd$$If\rp#n.$4 a sgg $d$Ifa$ $d$Ifa$d$IfVDG^pkd$$If\rp#n.$4 a }q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkd.$$If\rp#n.$4 a !}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a!"JLU^}qWW'$ d$&dIfPa$ $d$Ifa$Zd$If^Z`pkdF$$If\rp#n.$4 aQTUX[^_aȷwncRIC6ChCJPJnHo(tH hCJh>*CJaJ h>*CJOJQJnHo(tHh>*CJOJQJh5CJo(-h5B*CJOJPJQJnHo(phtH!h5B*CJOJQJo(phhB*PJnHo(phtHhCJaJ!hCJOJPJQJnHo(tHhCJOJPJQJnHtH*hB*CJOJPJQJnHo(phtH!hCJOJPJQJnHo(tH^_`agggbQ@%$!d$Ifa$d$If^`d&9TPL HD@<+{d<^pkdҌ$$If\rp#n.$4 as^^$d$&dIfPa$ $d$Ifa$Zd$If^Z`]kd^$$IfFrp#n0 .$    4 a%$!d$Ifa$ $%@DEGHt!"$*34589:;^gsu~̽̽̽̽̽̽ծ̽hCJPJaJnHo(tHhCJPJaJnHo(tHhCJaJo(hCJaJhCJo( hCJhCJaJhCJPJnHo(tHD}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdn$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a{oZZ$d$&dIfPa$ $d$Ifa$Xd$IfWD^X`pkd$$If\rp#n.$4 a !"#$}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a$%ABCD}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 aDEt{rff $d$Ifa$ d$Ifd$IfWD^`pkd*$$If\rp#n.$4 a{occ $d$Ifa$ $d$Ifa$d$IfWD^`pkd$$If\rp#n.$4 a#$*ycD$d$&dIfPWD^`a$$d$IfWD^`a$7sd$IfVDGWD^7`spkdB$$If\rp#n.$4 a*+45678:o^RFF $d$Ifa$ $d$Ifa$Zd$If^Z`pkdΒ$$If\rp#n.$4 a$d$&dIfPWD^`a$:;tu~{oZZ$d$&dIfPa$ $d$Ifa$d$IfWD^`pkdZ$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkdr$$If\rp#n.$4 a #$%45>?@FKLMNQRST[bcdfghijlmռ򥝉yhPJnHo(tH ho(&hB*CJPJaJnHo(phtHhB*phhB*PJnHo(phtH *hCJ!hCJOJPJQJnHo(tHhCJaJhCJo(hCJPJnHo(tHhCJaJo(hCJaJ hCJ*}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$If\rp#n.$4 a$sgg $d$Ifa$ $d$Ifa$d$IfVDG^pkd$$If\rp#n.$4 a$%?@FLs^^$d$&dIfPa$ $d$Ifa$d$IfVDG^pkd$$If\rp#n.$4 aLMNOPQsgg $d$Ifa$ $d$Ifa$d$IfVDG^pkd.$$If\rp#n.$4 aQRST[c{oZZ$d$&dIfPa$ $d$Ifa$Zd$If^Z`rkd$$If \rp#n.$4 acdefgh}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdJ$$If\rp#n.$4 ahijmgg__YP $$Ifa$$If$da$&9TPL HD@<+{d<^pkd֘$$If\rp#n.$4 a&'(ʷʤʤvvvvkv\hCJPJaJnHo(tHh5CJ\aJ%h>*CJOJPJQJaJnHtHhCJOJQJaJh>*CJPJaJnHtH%hCJOJPJQJaJnHo(tH%hCJOJPJQJaJnHo(tH"hCJOJPJQJaJnHtHhCJo( hCJhCJaJh5CJPJnHo(tH!VPG $$Ifa$$Ifpkdb$$If\rY#F$4 a%$!xd0$&dIfPUD2]xa$%$!d8$&dIfPa$wqh $$Ifa$$Ifpkd$$If\rY#F$4 a%$!xd0$IfUD2]xa$hh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd $$If\rY#F$4 a&')-ybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 a(,-LMTW\]^wx 3:>?BCDY^`adefhijmvıۣıۣıۣĚۣӱۣӱۣӱۣӱhCJaJo(hCJPJaJnHtH%hCJOJPJQJaJnHo(tHhCJPJaJnHo(tHhCJaJ%h>*CJOJPJQJaJnHtH"hCJOJPJQJaJnHtH<-.LMU]ybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$$If\rY#F$4 a]^wxybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd<$$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkdȝ$$If\rY#F$4 a ybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkdT$$If\rY#F$4 a23;Cybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 aCDXY_eyZZ%$!xd0$&dIfPUD2]xa$ $$Ifa$ $IfWDd`pkdl$$If\rY#F$4 aefghijhh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ajklmw``%$!xd0$&dIfPUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 avw KPRSVWXipqȩȩȩȩȩȩhCJaJo(hCJPJaJnHo(tHhCJPJaJnHtHh5CJaJhCJaJ%h>*CJOJPJQJaJnHtH%hCJOJPJQJaJnHo(tH"hCJOJPJQJaJnHtH9hh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd($$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd@$$If\rY#F$4 a JKQWybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkḍ$$If\rY#F$4 aWXhimqybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkdX$$If\rY#F$4 aqrybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 ayZZ%$!xd0$&dIfPUD2]xa$ $$Ifa$ $IfWDd`pkdp$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 a +,/012GHIJcemotuvȺȺȩȩȩ|ȺȺȺhCJPJaJnHo(tH(h5>*CJOJPJQJaJnHtHh5CJaJhCJaJhCJaJo(hCJPJaJnHtH%h>*CJOJPJQJaJnHtH%hCJOJPJQJaJnHo(tH"hCJOJPJQJaJnHtH/ yZZ%$!xd0$&dIfPUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 a",``%$!xd0$&dIfPUD2]xa$ $$Ifa$$Ifpkd,$$If\rY#F$4 a,-./01hh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 a12FGHIhh%$!xd0$IfUD2]xa$ $$Ifa$$IfpkdD$$If\rY#F$4 aIJcemuybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkdЩ$$If\rY#F$4 auvybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd\$$If\rY#F$4 aybb%$!xd0$IfUD2]xa$ $$Ifa$ $IfWDd`pkd$$If\rY#F$4 ayZZ%$!xd0$&dIfPUD2]xa$ $$Ifa$ $IfWDd`pkdt$$If\rY#F$4 a >?HIRSTYnð՝Ý՝ݔ՝ÝðՔ՝ÝՉzh#hB*CJPJaJnHphtHhCJPJaJnHo(tHh5CJ\aJh5CJaJ%hCJOJPJQJaJnHo(tH%h>*CJOJPJQJaJnHtH"hCJOJPJQJaJnHtHhCJaJhCJPJaJnHtH(h>*CJOJPJQJaJnHo(tH(hh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 a``%$!xd0$&dIfPUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 a ``%$!xd0$&dIfPUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 ahh%$!xd0$IfUD2]xa$ $$Ifa$$Ifpkd0$$If\rY#F$4 a>?IS``%$!xd0$&dIfPUD2]xa$ $$Ifa$$Ifpkd$$If\rY#F$4 aSTUVWX}qqq $d$Ifa$Zd$If^Z`pkdH$$If\rY#F$4 aXYnopq}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkdԯ$$Ifl\Y#$$"4 laqrsgg $d$Ifa$ $d$Ifa$d$IfWDd`pkd\$$Ifl\Y#$$"4 la67=@AEKXYbclmsϽ۲۲۩hCJaJo(h5CJ\aJ#h= hCJPJaJnHo(tHh= hCJaJo(hCJaJhCJPJaJnHo(tHhCJPJaJnHtH?ymaa $d$Ifa$ $d$Ifa$nd$IfVDGWD2^`npkd$$Ifl\Y#$$"4 laymXX$d$&dIfPa$ $d$Ifa$nd$IfVDGWD2^`npkdl$$Ifl\Y#$$"4 la}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$Ifl\Y#$$"4 la}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd|$$Ifl\Y#$$"4 la67>E}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkd$$Ifl\Y#$$"4 laEFGHIJ}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$Ifl\Y#$$"4 laJKXYcm}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkd$$Ifl\Y#$$"4 lamnopqr}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$Ifl\Y#$$"4 lars}qee $d$Ifa$ $d$Ifa$Zd$If^Z`pkd$$$Ifl\Y#$$"4 lasgg $d$Ifa$ $d$Ifa$d$IfWDd`pkd$$Ifl\Y#$$"4 laymaa $d$Ifa$ $d$Ifa$nd$IfVDGWD2^`npkd4$$Ifl\Y#$$"4 laymXX$d$&dIfPa$ $d$Ifa$nd$IfVDGWD2^`npkd$$Ifl\Y#$$"4 lasgg $d$Ifa$ $d$Ifa$d$IfVDG^pkdD$$Ifl\Y#$$"4 la xlWW$d$&dIfPa$ $d$Ifa$%!Zd$If^Z`pkd̷$$Ifl\Y#$$"4 la $%&*+,2368<=JKUV`ahipqtdzvvvvvvvbWh5CJ\aJ&hB*CJPJaJnHo(phtH$h5@B*CJ\aJo(ph!h5@B*CJ\aJph0h5@B*CJPJ\aJnHo(phtH&hB*CJPJaJnHo(phtHhB*phhCJPJaJnHtHhCJPJaJnHo(tHhCJaJhCJOJQJaJ! xl`` $d$Ifa$ $d$Ifa$%!Zd$If^Z`pkdT$$Ifl\Y#$$"4 la%}q\\$d$&dIfPa$ $d$Ifa$Zd$If^Z`pkdܸ$$Ifl\Y#$$"4 la%&+,pqe__]PGd^ d^`^&9TPL HD@<+{d<^rkdd$$Ifl?\Y#$$"4 lat%()`dik28@{}~ )ঔѺѺ h5CJPJ\aJnHtH#hB*CJPJaJnHphtH&hB*CJPJaJnHo(phtHhCJaJo(hCJPJaJnHtHhCJPJaJnHo(tHhCJaJh5CJ\aJh5CJ\aJo(3xUkd$$If0"0 t644 la$$7$8$H$Ifa$d & Fd1$$da$ $d^a$ KLM^_tuvټǼټǼ٭Ǚٙ}sټټټټǼhCJPJ aJhB*PJ aJnHphtHhB*PJ aJph& *hB*CJPJ aJnHphtH *hCJPJ aJnHtH *hCJPJ aJ#hB*CJPJ aJnHphtHhB*CJPJ aJph *hCJaJhCJPJaJnHo(tH)LUkdX$$If$0"0 t644 la$[$7$8$H$IfWD^`[a$$$7$8$H$Ifa$LM_uvz$Ukd($$If0"0 t644 la{$$$IfWD^`$a$$n$7$8$H$IfWD^n`a$Ukd$$If0"0 t644 lavEUkd$$If0"0 t644 laUkd$$If0"0 t644 la$$7$8$H$Ifa$!">Z[\E9 $d7$8$H$a$Ukdȼ$$If0"0 t644 laUkd`$$If0"0 t644 la$$7$8$H$Ifa$!">Z[ WXxy+,|}Dͻՙխխ򙭉{pg{{pghCJ]aJhCJH*]aJhCJPJaJnHtH *hB*CJPJ aJph&hB*CJH*PJ aJnHphtHhB*CJPJ aJph#hB*CJPJaJnHphtHhCJaJ#hB*CJPJ aJnHphtH *hCJPJ aJhCJPJ aJnHtH(\ YZcziUkd0$$If0"0 t644 la$$7$8$H$IfWD^`a$$$7$8$H$Ifa$$da$$d7$8$H$VD^a$z{EUkd$$If0"0 t644 la$$7$8$H$Ifa$Ukd$$If0"0 t644 la-.AEUkdо$$If0"0 t644 la$$7$8$H$Ifa$Ukdh$$If0"0 t644 laA~-Ukd$$If0"0 t644 la$$7$8$H$Ifa$Ukd8$$If0"0 t644 la$$7$8$H$IfWD^`a$D01cd{| ,VD]^ ,BVD]^B & F7$8$H$ d^`^ $d^a$$d7$8$H$VDWD^`a$$d7$8$H$VD^a$DEF-./19NL~(.6acdg{|qrֶ֧֧qjdj haJhaJo(h5CJPJaJnHtHh5CJ\o(h5CJ\&hB*CJPJaJnHo(phtHh6CJPJaJnHtHhCJPJaJnHo(tH hCJH*PJ]aJnHtHhCJPJaJnHtHhCJaJhCJ]aJhCJH*]aJ% Z[]^xz{ $&(򾷧xf#hB*CJPJaJnHphtHhB*CJaJphh5CJPJaJnHtH&h5B*CJPJaJnHphtHh5>*CJPJnHo(tHhaJo( haJhCJ]aJhCJPJaJnHtHhCJaJhCJPJaJnHo(tHhPJaJnHo(tH& YPLkdy$$If0p#/ !4 a8Lkd$$If0p#/ !4 a8 $d$Ifa$ d$IfYZ[\]z\P $d$Ifa$Lkda$$If0p#/ !4 a8 d$IfLkd$$Ifq0p#/ !4 a8\P $d$Ifa$LkdU$$If0p#/ !4 a8 d$IfLkd$$If0p#/ !4 a8 "$&(PD8 ,BVD]^B ,VD]^LkdI$$If0p#/ !4 a8 $d$Ifa$ d$IfLkd$$If0p#/ !4 a8#@A$d$$&dIfPa$&d$$If^`&$\d$VDQ^\`a$$\#d$VDQ^\`#a$A7$8$H$VD^`A 7$8$H$VD^ & FH7$8$H$^`Hd#$AVfno |q|`||WhCJ]aJ hCJPJ]aJnHo(tHhCJ]aJo(hCJPJ]aJnHtHhB*CJaJphh>*B*CJphhCJPJaJnHtHhCJPJaJnHo(tHhCJaJh>*B*CJaJph&h>*B*CJPJaJnHphtH)h>*B*CJPJaJnHo(phtH"AWXYfghn$d$$&dIfPa$nop,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8px $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$ ,qd$$IfVDWD^`qkd$$If֞ ^> $nnn0"4 a8 %/1$d$$&dIfPa$$%./1239:<AHIPQXY`ajktuvw}~ &(ηη׷Φצצ hCJPJ]aJnHo(tHhCJPJ]aJnHtHhCJaJhCJ]aJhB*CJaJphhCJPJaJnHo(tHhCJPJaJnHtHA123,&d$$If^`&kd$$If֞ ^> $nnn0"4 a83456789 $d$$Ifa$9:A,qd$$IfVDWD^`qkd$$If֞ ^> $nnn0"4 a8AIQYaku$d$$&dIfPa$uvw,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8wxyz{|} $d$$Ifa$}~,qd$$IfVDWD^`qkd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$$d$$&dIfPa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd"$$If֞ ^> $nnn0"4 a8 $d$$Ifa$ (,&d$$If^`&kd,$$If֞ ^> $nnn0"4 a8(*,.02B $d$$Ifa$(2@BD`jxz| "$02F|ννεΦεב}}oh>*B*CJaJph&h>*B*CJPJaJnHphtH)h>*B*CJPJaJnHo(phtHhCJPJ]aJnHtHhCJaJ hCJPJ]aJnHo(tHhCJ]aJhB*CJaJphhCJPJaJnHo(tHhCJPJaJnHtH+BD`,&d$$If^`&kd6$$If֞ ^> $nnn0"4 a8`bdfhjz $d$$Ifa$z|,&d$$If^`&kd@$$If֞ ^> $nnn0"4 a8$d$$&dIfPa$ $d$$Ifa$,&d$$If^`&kdJ$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kdT$$If֞ ^> $nnn0"4 a8  $d$$&dIfPa$ $d$$Ifa$ "$,&d$$If^`&kd^$$If֞ ^> $nnn0"4 a8$&(*,.0 $d$$Ifa$024,$\#d$VDQ^\`#a$kdv$$If֞ ^> $nnn0"4 a84&'(567=$d$$&dIfPa$&d$$If^`&$\d$VDQ^\`a$A7$8$H$VD^`A%5=>opwx %&-.78ABCDJKSaghn³™³ªªªª hCJPJ]aJnHo(tHhCJ]aJhCJPJ]aJnHtHhB*CJaJphh>*B*CJphhCJaJhCJPJaJnHtHhCJPJaJnHo(tH<=>?,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8?GOW_go $d$$Ifa$opq,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8qrstuvw $d$$Ifa$wx,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,qd$$IfVD&WD^`qkd$$If֞ ^> $nnn0"4 a8$d$$&dIfPa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,qd$$IfVDWD^`qkd$$If֞ ^> $nnn0"4 a8&.8B$d$$&dIfPa$BCD,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8DEFGHIJ $d$$Ifa$JKa,qd$$IfVDWD^`qkd$$If֞ ^> $nnn0"4 a8ahow}~ $d$$Ifa$$d$$&dIfPa$novw|~ %)349>?@AEGHO[`ghi׷צצΦΦηחhCJPJaJnHo(tH hCJPJ]aJnHo(tHhCJPJ]aJnHtHhCJaJhCJ]aJhB*CJaJphhCJPJaJnHo(tHhCJPJaJnHtH5,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,# d$$Ifkd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8 $d$$Ifa$,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8  $d$$Ifa$4,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8456789?$d$$&dIfPa$ $d$$Ifa$?@A,&d$$If^`&kd$$If֞ ^> $nnn0"4 a8ABCDEFG $d$$Ifa$GH[,&d$$If^`&kd"$$If֞ ^> $nnn0"4 a8[\]^_`g$d$$&dIfPa$ $d$$Ifa$ghi,$$da$kd,$$If֞ ^> $nnn0"4 a8i<bsxrvz|~ɵ~~~i_VGhCJPJaJnHo(tHhCJ]aJhPJnHtH)h>*B*CJPJaJnHo(phtHh>*B*CJaJph&h>*B*CJPJaJnHphtH)h5B*CJPJaJnHo(phtH&h5B*CJPJaJnHphtHh5>*CJPJnHo(tH&hB*CJPJaJnHo(phtH#hB*CJPJaJnHphtHi@Bprm$d$$&dIfPa$&d$$If^`& $d$`a$$\d$VDQ^\`a$$d$WD`a$$d$a$ & FH7$8$H$^`HdA7$8$H$VD^`A$-7$8$H$VD^-a$ +345]^_dest}~ƷϦƷϷ)h>*B*CJPJaJnHo(phtH hCJPJ]aJnHo(tHhCJPJ]aJnHtHhCJ]aJhB*CJaJphhCJPJaJnHo(tHhCJaJhCJPJaJnHtH2,-34QkdD$$Ifֈq mE# nnt"4 a8$d$$&dIfPa$45=EMU]^_Ikd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$&d$$If^`&_`abcdet~ZI&d$$If^`&kd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$~ZI&d$$If^`&kd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$ZI&d$$If^`&kd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$E4&d$$If^`&kdO$$Ifֈq mE# nnt"4 a8$d$$&dIfPa$ $d$$Ifa$ZI&d$$If^`&kd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$5kd$$Ifֈq mE# nnt"4 a8$&d$$&dIfP^`&a$$&d$$If^`&a$BD^$d$$&dIfPa$&d$$If^`& $d$`a$ @BDF\^`&(*46RTĵğğĂğsshCJPJ]aJnHtH hCJPJ]aJnHo(tHhB*CJaJphhCJaJhCJPJaJnHtHhCJPJaJnHo(tHhCJ]aJhPJnHtH)h>*B*CJPJaJnHo(phtH&h>*B*CJPJaJnHphtH-&fUIIIII $d$$Ifa$&d$$If^`&kd$$Ifֈq mE# nnt"4 a8&(*,.024fUIIIII $d$$Ifa$&d$$If^`&kd$$Ifֈq mE# nnt"4 a846ThxfUIIIII $d$$Ifa$&d$$If^`&kdZ$$Ifֈq mE# nnt"4 a8fUIIIII $d$$Ifa$&d$$If^`&kd)$$Ifֈq mE# nnt"4 a8fUIIII $d$$Ifa$&d$$If^`&kd$$Ifֈq mE# nnt"4 a8    Q@44 $d$$Ifa$&d$$If^`&kd$$Ifֈq mE# nnt"4 a8$d$$&dIfPa$  $(2341;>m{۶䘆rrrrrrrrrbYh5CJ\h5>*CJPJnHo(tH&hB*CJPJaJnHo(phtH#hB*CJPJaJnHphtHhCJPJaJnHo(tHhCJPJaJnHo(tHhCJPJaJnHtHhCJPJ]aJnHtHhCJaJhCJ]aJhB*CJaJphhCJPJaJnHo(tH $%&'ZI&d$$If^`&kd$$Ifֈq mE# nnt"4 a8 $d$$Ifa$'(234E@4 $d$^a$$a$kde$$Ifhֈq mE# nnt"4 a8$d$$&dIfPa$ $d$$Ifa$-.pqrq^#qd$IfWD^`qOkd4$$If440B# T"4 a8f4 $d$Ifa$ d$If $d`a$ $d^a$ d^`d ,-.@Hcnoq%&,23UVZ^_kżŗŗŶŪŪśżśhCJaJnH o(tH hhCJPJaJnHo(tHhCJaJnH tH hCJhCJaJo(hCJaJhCJPJ\nHo(tHhCJ\o(hCJ\h5CJ\h5CJ\o(6uii $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4$d$&dIfPa$~~ $d$Ifa$#qd$IfWD^`qbkd6$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkdZ$$If44FBY#T"    4 a8f4&,2~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f423VZ^~~ $d$Ifa$#qd$IfWD^`qbkdr$$If44FBY#T"    4 a8f4^_~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4 ~p$d$4$Ifa$ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4 +49;<Dtu          % & ' @ A B D E M ׳ׄπππwhCJ]aJhhCJaJnH tH hCJ\hCJ\o(h5CJ\o(h5CJ\hCJPJ\nHo(tHhCJaJnH o(tH hCJaJ hCJhCJaJo(hCJnH tH hCJPJaJnHo(tH( +3;~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4;<u{uu$d$&dIfPa$#qd$IfWD^`qbkd.$$If44FBY#T"    4 a8f4 |mmdX $d$Ifa$ d$IfVdUD]V^ $d^a$ d^`$da$bkd$$If44FBY#T"    4 a8f4     $d$&dIfPa$#qd$IfWD^`qOkdF$$If440B# T"4 a8f4    % ~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4% & ' 3 @ ~~ $d$Ifa$#qd$IfWD^`qbkdH$$If44FBY#T"    4 a8f4@ A B C D ~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4D E |   ~~ $d$Ifa$#qd$IfWD^`qbkdl$$If44FBY#T"    4 a8f4M T ^ v y { |                             ú砌ú~tjcZcZchCJ\o(hCJ\h5CJ\o(hCJnH tH hB*CJaJo(ph&hB*CJPJaJnHo(phtHhCJaJnH tH hCJhCJaJhCJaJo(hCJPJaJnHo(tHh5CJaJh5CJ\]aJhCJ]aJhCJPJ]aJnHtH"     uu$d$&dIfPa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4     ~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4     uu$d$&dIfPa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4           sgg $d^a$ d^`^$VdUD]V^a$dbkd$$If44FBY#T"    4 a8f4      . = C D W e      % & D P        {           #)128?EHNOT]¹hCJPJnHtHhCJPJnHo(tHhCJo( hCJh5CJPJ\nHo(tHh5CJ\h5CJ\o(&hB*CJPJaJnHo(phtHhCJ\o(hCJ\h5CJh5CJo(3,.68Ez !()`deݳ~w~w~jw~[~[~w[~[hCJPJ\nHo(tHhCJPJ\nHtHhCJ\hCJ\o(h5>*CJh5CJPJ\nHo(tHh5CJ\h5CJ\o(&hB*CJPJaJnHo(phtHhCJPJaJnHtHhCJaJhCJPJaJnHo(tH hCJhCJPJnHo(tH#)* $d$Ifa$ d$If$HdVDWD8^`Ha$ d^`^d^ $d^a$ ,-fgＫ}tj}h5CJ\o(h5CJ\h5CJPJ\nHo(tH&hB*CJPJaJnHo(phtHhCJnH tH !hCJPJQJaJnHo(tHhCJPJaJnHtHhhCJPJaJnHo(tHhCJaJnH tH hCJhCJaJo(hCJaJ)$d$&dIfPa$#qd$IfWD^`qOkd.$$If440B# T"4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkd0$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4~~ $d$Ifa$#qd$IfWD^`qbkdT$$If44FBY#T"    4 a8f4uuuuuuuu$d$&dIfPa$#qd$IfWD^`qbkd$$If44FBY#T"    4 a8f4 xccc$d$&dIfPa$ d$Ifd^ d^`^bkdl$$If44FBY#T"    4 a8f4FMNUWz9@AHJKNOUV\^ϾϾϡϡϡϡϡϡϡϡϡϡϡϡUhCJOJQJaJnHtHhCJOJQJaJhCJPJaJnHtHh>*CJPJaJnHtH h>*CJPJaJnHo(tHhCJPJaJnHo(tHhCJaJo(hCJaJ hCJh5CJ\o(3 .]kdd$$IflF#&T"    4 la $d$Ifa$ d$If]kd$$IflF#&T"    4 la%&'()]kd$$IflF#&T"    4 la #$d$Ifa$ d$If)*FNVW.]kd$$IflF#&T"    4 la #$d$Ifa$ d$If]kd<$$IflF#&T"    4 laW{rff #$d$Ifa$ d$If]kd $$IflF#&T"    4 la#$d$&dIfPa$d$If^`~~$d$&dIfPa$%!d$If]kd $$IflF#&T"    4 la/]kdX $$IflF#&T"    4 la $$Ifa$ %!$If]kd $$IflF#&T"    4 la9AI|gg#$d$&dIfPa$d$If^`]kd $$IflF#&T"    4 la $$Ifa$ %!$IfLess : Allowance for doubtful debts of other receivables(7,838)(7,838)50,57141,876Total trade and other receivables415,289314,353Included in the trade and bills receivables are debtors and bills receivables, net of allowance for bad debt and doubtful debts, with the following ageing analysis:30 June 201031 December 2009RMB000RMB000(unaudited)(audited) Within one year362,199270,571More than one year but less than two years2,1711,503More than two years but less than three years348403364,718272,477The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agreed upon in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30 days to its local trade customers and 90 days for local hospital customers. 9. Trade and other payablesThe following is an aged analysis of accounts payable presented based on the invoice date at the end of the reporting period.30 June 201031 December 2009RMB000RMB000(unaudited)(audited)Within one year382,667269,164More than one year but less than two years1,2144,987More than two years but less than three years758747Over three years5,1825,436389,821280,334Other payables and accrued charges217,037211,364606,858491,69810. Related party transaction Significant related party transactions, which were carried out in the normal course of the Groups business are as follows:Six months ended 30 June20102009RMB000RMB000(unaudited) (unaudited)SXPGC - Payment of annual trademark license fee (Note)1,1001,100 - Rental expense500500Fellow subsidiaries :- Sale of water, electricity, steam and waste materials6,4865,441- Purchase of raw materials28,44942,690- Rental income-2Associates- Purchase of raw materials4,8241,584- Rental income-132- Design fee income-11Minority shareholder:- Sale of bulk pharmaceuticals and chemical raw materials67,69471,620Note:On 7 December 1996, the Group was granted the exclusive right to use the trademark Xinhua (Trademark) by Shandong Xinhua Pharmaceutical Group Company Limited (SXPGC) for its existing and future products in and outside the PRC at an initial annual fee of RMB600,000 increasing at the rate of an extra RMB100,000 per year until the annual fee reaches the cap amount of RMB1,100,000, which shall stay as such until the agreement is terminated. The terms of the agreement shall continue to have effect during the validity period of the Trademark, being 28 February 2013, subject to further renewal of the registration of the Trademark. During the six months ended 30 June 2010, the annual fee paid by the Group was RMB1,100,000 (2009 : RMB1,100,000). As at 30 June 2010, Hualu Holdings Company Limited provide guarantee to the Group amounted to RMB230,000,000 (2009: RMB150,000,000). Compensation of key management personnelSix months ended 30 June20102009RMB 000RMB 000(unaudited) (unaudited)Short-term benefits9371,016Post-employment benefits1171171,0541,133i!. DOCUMENTS FOR INSPECTION AND PLACE FOR INSPECTION(1) DOCUMENTS FOR INSPECTION1. The original copy of the Companys 2010 interim report signed by the Chairman of the Board.2. Financial statements for the six months ended 30 June 2010 signed by the Chairman of the Board, the financial controller and the chief of the accounting department of the Company.(2) PLACE FOR INSPECTIONOffice of the Secretary to the Board of the Company.By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedGuo QinChairman28 July 2010, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Ms. Guo Qin (Chairman)Mr. Ren FulongMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. Sun MinggaoMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Liu Zhenwen Mr. Xu Lie Mr. Zhao BinPAGE PAGE 14IJKLMN/]kd $$IflF#&T"    4 la $$Ifa$ %!$If]kd0 $$IflF#&T"    4 laNOV]^_`a{{ $$Ifa$]kd $$IflF#&T"    4 la$$&dIfPa$ %!$If^_b:<=?HKMN[]^_opq؁فށ߁ʼʼʎ~~sʔsʔ *hCJaJo(hhCJaJnH tH hCJhCJaJo(hCJ\hCJ\o(hCJPJ\nHo(tHhCJPJaJnHtHhCJPJaJnHo(tH%hCJOJPJQJaJnHo(tHhCJaJhCJOJQJaJ+ab$$&dIfPa$ %!$If]kdt $$IflF#&T"    4 la;<=FK]zzz$d$&dIfPa$ d$Ifd^]kd $$IflF#&T"    4 la]^_go $d$Ifa$#qd$IfWD^`q]kdL$$IfF#&U"    4 a8opq} $d$Ifa$#qd$IfWD^`q]kd$$IfF#&U"    4 a8 $d$Ifa$#qd$IfWD^`q]kdR$$IfF#&U"    4 a8 $d$Ifa$#qd$IfWD^`q]kd$$IfF#&U"    4 a8ف߁ $d$Ifa$#qd$IfWD^`q]kdX$$IfF#&U"    4 a8 $d$Ifa$#qd$IfWD^`q]kd$$IfF#&U"    4 a8 !")*1234@Gɂ؂IKLX^m}ɽɽɣ㬑}ohhCJ\hCJPJaJnHtH&hB*CJPJaJnHo(phtH#hB*CJPJaJnHphtHhCJ\o(hCJaJ *hCJaJhCJaJnH tH hCJhCJaJo( *hCJaJo(hCJPJaJnHo(tHhCJaJnH o(tH $  $d$Ifa$#qd$IfWD^`q]kd^$$IfF#&U"    4 a8 !"*2yy$d$&dIfPa$#qd$IfWD^`q]kd$$IfF#&U"    4 a8234567ymmmd d$If $d^a$ d^`^ $d^a$d^]kdd$$IfF#&U"    4 a8 #,46BEUWXYijkф݄҄ބ߄ º|x|x||obobhCJaJnH o(tH hCJaJo(hhCJaJnH tH hCJhCJPJ\nHo(tHhCJPJaJnHtHhCJPJaJnHo(tHhCJaJhCJ\h5CJ\o(h5CJ\h5CJPJ\nHo(tH&hB*CJPJaJnHo(phtH&7@EWXYaiymm $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8$d$&dIfPa$ijkw $d$Ifa$#qd$IfWD^`q]kdj$$IfFBY#T"    4 a8 $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8 $d$Ifa$#qd$IfWD^`q]kdp$$IfFBY#T"    4 a8҄؄ބ $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8ބ߄ $d$Ifa$#qd$IfWD^`q]kdv$$IfFBY#T"    4 a8&'2345789ABIJlm|}~345IṰwwwnhCJ\o(hCJPJ\nHo(tHh5>*CJhCJ\h5CJ\o(h5CJPJ\nHo(tHh5CJ\&hB*CJPJaJnHo(phtHhCJaJnH tH hCJaJ hCJhCJaJo(hCJPJaJnHo(tH+'-3yy$d$&dIfPa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a834567 $d$Ifa$#qd$IfWD^`q]kd|$$IfFBY#T"    4 a8789AI $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8IJmu}yy$d$&dIfPa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8}~ $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8yy$d$&dIfPa$#qd$IfWD^`q]kd$$IfFBY#T"    4 a8456Opg[ $d$Ifa$ d$If$ & FSWd1$^S`Wa$d^ d^`^]kd $$IfFBY#T"    4 a8IOPQSVY[\]mnodžȆΆӆԆՆֆ   5;DEKQRmnu|}ɠ(h5CJOJPJQJaJnHo(tH%hCJOJPJQJaJnHo(tHh5CJaJnH tH h5CJaJhCJaJhhCJPJaJnHo(tHhCJaJnH tH hCJhCJaJo(6OPQV[$d$&dIfPa$#qd$IfWD^`qOkd$$If440B#} 9!4 aSf4[\]em~~ $d$Ifa$#qd$IfWD^`qbkd$$If44FBY#}9!    4 aSf4mno| $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#}9!    4 aS $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#}9!    4 aS $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#}9!    4 aSȆΆԆ $d$Ifa$#d$IfVDg^`]kd$$IfFBY#}9!    4 aSԆՆ $d$Ifa$#d$IfVDG^]kd$$IfFBY#}9!    4 aS $d$Ifa$#d$IfVDG^]kd$$IfFBY#}9!    4 aS    $d$Ifa$#qd$IfWD^`q]kd$$IfFBY#}9!    4 aS EKQ $d$Ifa$#d$IfVDg^`]kd%$$IfFBY#}9!    4 aSQRnu| $d$Ifa$#d$IfVDg^`]kd$$IfFBY#}9!    4 aS|} $d$Ifa$#d$IfVDg^`]kd+$$IfFBY#}9!    4 aSƇ͇̇Շ܇݇߇HMVW^efgln̈ԿԨԨԨԿԨڨԐhCJ\o(hCJ\.hB*CJOJPJQJaJnHo(phtHhCJaJh5CJaJnH o(tH h5CJaJhCJaJnH tH hCJhCJPJaJnHo(tHhCJaJnH o(tH hCJaJo(/ $d$Ifa$#d$IfVDg^`]kd$$IfFBY#}9!    4 aS.]kd$$IfFBY#}9!    4 aS $d$Ifa$ #d$If]kd1$$IfFBY#}9!    4 aSƇ͇̇݇߇u#d$If^]kd7 $$IfFBY#}9!    4 aS $d$Ifa$#d$IfVDg^` $d$Ifa$#d$IfVDg^`]kd $$IfFBY#}9!    4 aS $d$Ifa$#d$IfVDg^`]kd=!$$IfFBY#}9!    4 aS $d$Ifa$#d$If`]kd!$$IfFBY#}9!    4 aSMW^eydd$d$&dIfPa$#d$IfVDgWD^`#d$IfVDg^`]kdC"$$IfFBY#}9!    4 aSefgmnab}qiTH $Sd^Sa$$ & FSWd1$^S`Wa$$da$ $>d^>a$ $d^a$$ndWD2^`na$^]kd"$$IfFBY#}9!    4 aS̈ՈۈNO`adehkrtuŋNjՋ֋ۋ݋*,.VbdfjжУhCJaJnH tH hCJhCJaJo(hCJaJ$hCJOJPJQJ\nHo(tH hCJPJ\aJnHo(tHhCJ\o(hCJPJ\nHo(tHh5CJaJhCJ\aJhCJ\h5CJ,,.0bdfpzmXX$d$&dIfPa$#qd$IfWD^`qOkdO#$$If440B#} 9!4 aSf4 $d$Ifa$ d$If|`$ & FSWd1$^S`Wa$jpvz|~Ԍ֌،܌ތ LNTV^bdjtvڍ܍ϼ׭Ϣϭϊ~~d~3h5CJKHOJPJQJ\^JaJnHo(tH h5 h5o(.hB*CJOJPJQJaJnHo(phtH *hCJaJo(hCJPJaJnHo(tHh5CJaJnH tH hCJhCJaJhCJaJnH tH hhCJaJo(hCJPJaJnHo(tH'z|~~~ $d$Ifa$#qd$IfWD^`qbkd#$$If44FBY#}9!    4 aSf4Ԍ $d$Ifa$#qd$IfWD^`q]kdQ$$$IfFBY#}9!    4 aSԌ֌،ڌ܌ $d$Ifa$#qd$IfWD^`q]kd$$$IfFBY#}9!    4 aS܌ތ $d$Ifa$#qd$IfWD^`q]kdW%$$IfFBY#}9!    4 aSNV^$d$&dIfPa$ #d$If]kd%$$IfFBY#}9!    4 aS^`bdfh.]kd&$$IfFBY#}9!    4 aS $d$Ifa$ #d$If]kd]&$$IfFBY#}9!    4 aShjvwx/}uoooooo7$8$H$$da$^]kdc'$$IfFBY#}9!    4 aS$d$&dIfPa$ #d$If @BCDKLhivx͎̎ %&.0HIJ~ŏƏΏ֏׏؏ڏ}}n\#h56B*CJ\]aJphh6B*CJ]aJphh5B*CJ\aJphhB*CJaJph&hB*CJPJaJnHo(phtH)hB*CJKHOJQJ\aJo(ph&hB*CJKHOJQJ\aJph h5hCJ\o(hCJ\hCJPJ\nHo(tH h5o($/0IJƏΏ׏؏,-BYhy $$G$Ifa$$G$a$$^a$"$0TPL HD@< ^ a$$ ^ a$ ^ ^7$8$H$ڏۏߏqr !"#%&()+,./5679:@ACDEFGHIն hjCJ hCv0J$mHnHuhj hj0J$jhj0J$UhMJjhMJUhCJPJaJnHo(tH ho(hPJnHo(tHhPJnHtH&hB*CJPJaJnHo(phtHhB*CJaJph%yِؐڐ Gkd'$$If0!64 a $$G$Ifa$ !"$%'(*+-.789EFGHI#$a$##&`#$GkdC($$If0!64 a/0P/ =!"H#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBO> NotesdB*CJaJphHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJQJ_HaJmH nHphsH tHDZ@D ~e,g$a$CJOJPJQJ aJnHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.@". yblFhe,g"CJaJ6 @26 u#9r G$CJaJ)@A uxP@RP u w%!d1$CJKHOJPJQJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHuPQ@P ckee,g 3)$a$!B*CJOJPJaJnHphtHBL@B eg*$a$CJOJPJQJ aJnHtHvOv Report Text-+$d1$5$7$8$9DH$^a$KHPJaJmH sH tH VT@V e,gWW!,$:d1$]:^a$CJKHPJaJtH `O` Default-1$7$8$H$)B*CJPJ_HaJmH nHphsH tH*U@* c >*B*phXOX xl137/dd1$[$\$ CJKHOJPJQJaJnHtHpOp Body Single0$ (1$a$$B*CJPJ_HhmH phsH tH 2V@2 ]vc >*B* ph0`@"0 HTML 0W@W26]Be@2B  HTML @BP h4$<@&a$5CJ OJPJQJ\^JaJ K@ y|T5([@b( 5uP[N~{T6\J@r\ oRh7$d8<@&a$"5CJ KHOJPJQJ\^JaJ - [e,g48 ` @ 1$3$5$7$8$G$0CJKHOJ PJQJ ^J _HaJmH nHsH tH6%@6 [ON0W@W9G$ OJQJ^J.?@. ~_g:dVD4^d4/@4 Rh;8WD8^`8<2@< Rh 2<d8VDWD8^d`8<3@< Rh 3=d8VDWD8^d`8<4@< Rh 4>d8VDXWD8^d`8<5@< Rh 5?d8VD WD8^d`8,1@, RhS @ & F 0:@0 RhS 2 A & F 0;@"0 RhS 3 B & F 0<@20 RhS 4 C & F0=@B0 RhS 5 D & F4D@R4 Rhc~ExVD^8E@b8 Rhc~ 2FHxVD^H8F@r8 Rhc~ 3GxVDX^8G@8 Rhc~ 4HxVD ^8H@8 Rhc~ 5I4xVD^400@0 Rhyv&{S J & F46@4 Rhyv&{S 2 K & F47@4 Rhyv&{S 3 L & F48@4 Rhyv&{S 4 M & F49@4 Rhyv&{S 5 N & F$$vU_ 1O00vU_ 2PVD^00vU_ 3QHVD^H00vU_ 4RVDX^00vU_ 5SVD ^00vU_ 6T4VD^400vU_ 7U VD^ 00vU_ 8V| VDx^| 00vU_ 9W VD@^ $@$ ybleW[X*j* ybl;NY5\(^@( nf(Qz)Z,@@, ~{T[dVD4^dX$@X 6eON0W@W(\d&+D/G$VDx^d OJQJ^J$ $"}_ 1]0 0"}_ 2^VD^0 0"}_ 3_VD^00"}_ 4`XVDX^X00"}_ 5a VD ^ 00"}_ 6bVD^00"}_ 7cVD^00"}_ 8dxVDx^x00"}_ 9e@VD@^@6!6 "}_hf5OJQJ\^J8"8 lgCJOJPJ QJ^JaJ4#4 VhvU_h8VDWD8`8(+( >\le,giG$8Y8 ech~gVj-D M I@ Oo`hok8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_lVD^<.< _evU_hmxOJPJQJ^J(B@( ckee,gnx4M@4 ckeL)ۏoWDd`8C@8 ckee,g)ۏpxVD^8N@8 ckeL)ۏ 2qWD`0@"0 cke)ۏrWD`2P@22 ckee,g 2 sdxBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$TOrT 7h_1wdd1$XDdCJKHPJaJhmH sH tH 6O6 short_text1CJaJZOZ Table Texty$a$$B*CJPJ_HhmH phsH tH ZOZ Table Text Char$B*CJPJ_HhmH phsH tH JOJ body text{xx1$CJKHaJtH VOV RQk=|d1$WD`CJKHOJPJQJaJtH <O< tw4winMark<B* H*phl m #$##W'X'K00)0 K00@)0K00x)0K00)0K00)0qrsuv"DE)*LM56PQ4 x y      R S r s  3 = l m z   ' , - l q v { | } #$;L]cdu#)*y ()Q`ouv%78*<=z !'9:;de2;CDZahi (?IJWbmn |}.CDZhv'2=L[\ ()Zk|bo|\]xyz?FLX^_suw      G S Z f l m !! !,!3!?!F!G!H!!!!!<""""##M#Y#d#n#z#########0$>$?$n$x$$$$$$$$%%%%K%Y%Z%%%%%%%%%%%%:&&&''2'W'X'^'j'v'x'z'''''''''((()(X(b(l(n(p(((((((((')3)4)^)f)n)p)r)))))}-~-/////0D0Z0p0000000 11$1*1,1.1/1H1]1i1o1q1s1t11111111232=2B2D2F2G222222222233 3 3 33'3136383:3;3i33333333333333L4Q4Y4^4`4b4c4d4444 5051575C5L5M5f5r5{5|5555556 6 6T6^6g6h66666666667 77(727;7<77777777996;7;;;;;"?#?R?S??????@B@C@D@E@F@G@H@I@T@U@V@W@X@Y@e@n@t@x@~@@@@@@@@@@@@@@@AA)AHALAPATAUAfAAAAAAAAAAAAABBB!B"B2BUBYB]BaBbBrBBBBBBBBBBBBBBBBBBBCCCCCC4C:C>CDCECVC}CCCCCCCCCCCCCCCCCCDDDDDD D!D"D#D$D5D6D7D8D9D:DLDcDgDkDoDpDDDDDDDDDDDDDDDEEE EE,E2E8E>E?EKE]EaEeEiEjEpEqExE|EEEEFFCJDJzJ{JJJKKKKKKBLCLMMNN&O'O7O8OPPPP)R*RTT7U8UWWYZZZZZg\h\]]]B^D^E^A_B___ a a aaaacccc?f@fffiiejfjkkmm%n&nooooqq r rrr?s@sttuuvviwjwww|x}xyyyyzyzzzz}} ~ ~!"STzƈ͈̈ #*+4<DLTU\cjryzÉ "#7K_efsӊ&:@AG[ouvwȋڋۋ܋%4:ABl{nj֌ &GOpxďʏя؏ڏۏ 5=?GOYZu|~ƐАѐאߐ!"23PQҖӖxy67$%12wx ֡ס/Is  8EKZ\ḷף ,7=?ISwŤǤɤʤˤޥߥ /klx(<stu̪ͪ_`efq-:IJcuĴִ 2BTcdܵ-<KZhiŶƶ8J\npqķҷ߷ '45ظ%4CR`a}̹ڹ=IUcpqƺǺ5DSbpq̻ۻ!3ACDZ\^`abļʼϼм*+IXgw$%kyST./WXY_xyz{ &./ABHNO\]djk 45;ABPQYabcdefgy{)*189STZ`abcdefghovwxyz{| (0123?KLMNOPQjkryz{|}~*+4;<}~"#$%&'(TUVWXnov~$%&'/789:FPQRSTUVijklm56=DE]^elm .09ABlmsyz  !",67[\cjklmnopqr|"*+,-./012:BCDEFGH[\dlmnopqr #$&-./0123`akuv#+,<=DKLMNOPQRS[cdefghijku/]^r'=>Q{|NOc9:Y[EQRSTUc $%ijklmn$%VWXYnop} #+3:BDNOciqx /01234;<STUVWX^_nopqrs{|%&'(=>?Lij18@GMWYZ[\]^_`abiqy ()*+,-56EFGHIJRSabcdefnoz{./0EFSp !"#$,-./01234HLMNOYZ[xyz "*2:DEFGHIJKLjklmnvwxyz{|}~%123456MSYZ 28:;hrz{Z[\uvw| .5;<=-.>? !)123?LMNOPQRSTU%&'FGHQVhijrz{|$%&'()U\cd =CIJx| 6<BCquyz,289KOSTUVWXnopq$*01ACGH\^abcdef|}~NOz{| %&']^{|*2;<TU"<=>Xiu000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 -00000 0 0 0 0 0000000\0000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0--- - 0 w 0 0 w 0 0 w 0 0 w 0 0 w 0 0 w 0 0 0 0 0 000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0000 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000 0 0 0 0 00 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 !0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 !0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 "0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 y0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0000000000000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '0 '0 0 00000 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0     0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 0 %0 % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0  0 % % 0  0 % % 0  0 % % 0  0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 % % 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 00000000 000000000 0 0 0  0 0  0  { 0 0 0 0 0 0 0 0 0 0 0 0 0 000  0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 000000 00,,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 ,,0 00 00 000 0 00 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000 0 00 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 0000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000000000000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0000 0000 0 0000 00 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 00000000 00 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 000 000 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 #0 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 ## 0 0 0 0000 00 0|0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 # 0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 000000000000000000000000000 00000 0 00000 0 0 0@0I00@0I00@0I00@0I00@#0@#0@0@#0@#0@0I00l m  , - { | #$cd)*()uv78<= !9:CDhiIJmnCD[\()^_  l m !!F!G!####>$?$$$Y%Z%%%W'X'''(()(((3)4)))00.1/1s1t111F2G222 3 3:3;33333b4c40515L5M5{5|555 6 6g6h66666 77;7<777B@C@H@I@X@Y@~@@@@@@TAUAAAAA!B"BaBbBBBBBBBCCDCECCCCCCCDD#D$D9D:DoDpDDDDDE E>E?EiEjEEË͈*+TUyz"#ef@AuvڋۋABڏۏYZАѐɤʤklstIJcdhiŶƶpq߷45`apqƺǺpqCDabϼм*+$%xy ./NOjkABabfg89`aefvw{|01KLPQyz~;<"#'(WX~$%78PQUVlmDElmAByz 67jkop*+/0BCGHlmqr -.23uv+,KLPQcdhi]^=>{|9:QRTU ijlmNO ;<^_{|YZab56RSno,-34YZ DEKLvw}~1256YZ :;z{uv;< 12LMPQTU%&hiz{$%()cdIJ BCyz89STWXpq01GHabef~%&=>K00D0DDK00D0DDK00D0DD K0080K0080K0 08 w00K0 08w00K0 0 l0K0 0 l0K0 0 |0K000K0K000x00DK0000DK0000DK000@0DK000x0DK0 00!0DK0"00#0DK0$00% 0DK0&00'X0DK0(00)0DK0*00+{00DK0,00-{00DK0.00/|00DK00001P|00DK02003|00DK04005|00DK06007|00DK00'0DK00P0DK0<0,=}0)0fn#0% K0>0,?}0)0fn#0% K0@0,A~0)0fn#0% K0B0,CH~0)0fn#0% K00*(0)0fn#0% K00((0)0fn#0%K00Υ)0fn#0%K00$()0fn#0%K0L0$Ml0^8^7T^p^^^(^K0N0$O0^8^7T^p^^^(^K0P0$Qܑ0^8^7T^p^^^(^K0R0$S0^8^7T^p^^^(^K0T0$UL0^8^7T^p^^^(^K0V0$W0^8^7T^p^^^(^K0X0$Y0^8^7T^p^^^(^K0Z0$[0^8^7T^p^^^(^K0\0$],0^8^7T^p^^^(^K0^0$_d0^8^7T^p^^^(^K0`0$a0^8^7T^p^^^(^K0b0$cԓ0^8^7T^p^^^(^K0d0$e 0^8^7T^p^^^(^K0f0$gD0^8^7T^p^^^(^K0h0$i0^8^7T^p^^^(^K0j0$k0^8^7T^p^^^(^K0l0$m0^8^7T^p^^^(^K0n0$o80^8^7T^p^^^(^K0p0$qp0^8^7T^p^^^(^K0r0$s0^8^7T^p^^^(^K00lϥ^8^7T^p^^^(^K00lϥ^8^7T^p^^^(^K0x0 yP030oHK0z0 {030oHK0|0 }030oHK0~0 030oHK00xƏ30oHK00h0H03K000H03K000H03K000H03K00H0H03K000H03K009@H0K009@H0K009@H0K009@H0K009@H0K009@H0K009@H0K009@H0K009@H0K009@H0K000H03K000H03K000H03K00T0H03K000H03K00Ĝ0H03K000H03K0040H03K00l0H03K000H03K00ܝ0H03K000H03K00L0H03K00}H03K004}H03K00l}H03K00}H03K00}H03K00}H03K00L}H03K00}H03K00}H03K00}H03K00,}H03K00d}H03K00}H03K00}H03K00 }H03K00D}H03K00|}H03K00}H03K00}H03K00$}H03K00\}H03K00}H03K00}H03K00}H03K00<}H03K00t}H03K00}H03K00}H03K00, }H03K00d }H03K00 }H03K00 }H03K00 !}H03K00D!}H03K01|!}H03K01!}H03K01!}H03K01$"}H03K01 \"}H03K0 1 "}H03K0 1"}H03K01#}H03K01<#}H03K01t#}H03K01#}H03K01#}H03K01$}H03K01T$}H03K01$}H03K01$}H03K0 1!$}H03K0"1#4%}H03K0$1%l%}H03K0&1'%}H03K0(1)%}H03K0*1+&}H03K0,1-L&}H03K0.1/&}H03K0011&}H03K0213&}H03K0415,'}H03K0617(}H03K0819(}H03K0:1;()}H03K0<1=`)}H03K0>1?)}H03K0@1A)}H03K0B1C*}H03K0D1E@*}H03K0F1Gx*}H03K0H1I*}H03K0J1K*}H03K0L1M +}H03K0N1OX+}H03K0P1Q+}H03K0R1S+}H03K0T1U,}H03K0V1W8,}H03K0X1Yp,}H03K0Z1[,}H03K0 0!ƏH03K0 0!ƏH03K0 0!ƏH03K0b1c-}3HKZ K0d1e-}3HKZ K0f1g-}3HKZ K0h1i0.}3HKZ K0&0'\h3HKZ K0&0'\h3HKZ K0&0'\h3HKZK0p1q/}u3_ K0r1sH/}u3_ K0t1u/}u3_ K0v1w/}u3_ K0x1y/}u3_ K0z1{(0}u3_ K0|1}`0}u3_ K0~10}u3_ K010}u3_ K011}u3_ K01@1}u3_ K01x1}u3_ K011}u3_ K011}u3_ K01 2}u3_ K01X2}u3_ K012}u3_ K012}u3_ K013}u3_ K0,0-0u3_ K0,0-0u3_K013}u3_K015}u3_K015}u3_K015}u3_K0,0-u3_ K0,0-hu3_K01 6}0K01 6}0K01 7}0K01 H7}0K01 7}0K01 7}0K01 7}0K01 (8}0K01 `8}0K01 8}0K01 8}0K01 9}0K01 @9}0K01 x9}0K01 9}0K01 9}0K01  :}0K01 X:}0K01 :}0K01 :}0K01 ;}0K0001P0K0001P0K01;}0K01;}0K01<}0K01P<}0K01<}0K01<}0K01<}0K010=}0K01h=}0K01=}0K01=}0K01>}0K01H>}0K01>}0K01>}0K01>}0K01(?}0K01`?}0K01?}0K01?}0K01@}0K01@@}0K02x@}0K02@}0K02@}0K02 A}0K02 XA}0K0 2 A}0K0 2A}0K02D}0K02HD}0K02D}0K02D}0K02D}0K02(E}0K02`E}0K02E}0K02E}0K0 2!F}0K0"2#@F}0K0$2%xF}0K0&2'F}0K0(2)F}0K0*2+ G}0K0,2-XG}0K0.2/G}0K0021G}0K0223H}0K04258H}0K0627pH}0K04050K04050K0<2=I}0 K0>2?PI}0 K0@2AI}0 K0B2CI}0 K0D2EI}0 K0F2G0J}0 K0H2IhJ}0 K0J2KJ}0 K0L2MJ}0 K0N2OK}0 K0P2QHK}0 K0R2SK}0 K0T2UK}0 K0V2WK}0 K0X2Y(L}0 K0Z2[`L}0 K0\2]L}0 K0^2_L}0 K0`2aM}0 K0b2c@M}0 K0d2exM}0 K0f2gM}0 K0h2iM}0 K0j2k N}0 K0l2mXN}0 K0n2oN}0 K0p2qN}0 K0r2sO}0 K0t2u8O}0 K0v2wpO}0 K0x2yO}0 K0z2{O}0 K0|2}P}0 K0~2PP}0 K02P}0 K02P}0 K02P}0 K020Q}0 K02hQ}0 K02Q}0 K02Q}0 K02R}0 K02HR}0 K02R}0 K02R}0 K02U}0 K02U}0 K02U}0 K02,V}0 K02dV}0 K02V}0 K02V}0 K02 W}0 K02DW}0 K02|W}0 K02W}0 K02W}0 K02$X}0 K02\X}0 K02X}0 K02X}0 K02Y}0 K023? k}0 K0@3AXk}0 K0B3Ck}0 K0D3Ek}0 K0F3Gl}0 K0H3I8l}0 K0J3Kpl}0 K0L3Ml}0 K0N3Ol}0 K0P3Qm}0 K0R3SPm}0 K0T3Um}0 K0V3Wm}0 K0X3Ym}0 K0Z3[0n}0 K0\3]hn}0 K0^3_n}0 K0`3an}0 K0b3co}0 K0d3eHo}0 K0f3go}0 K0h3io}0 K0j3ko}0 K0l3m(p}0 K0n3o`p}0 K0p3qp}0 K0r3sp}0 K0t3uq}0 K0v3w@q}0 K0x3yxq}0 K0z3{q}0 K0|3}q}0 K0~3 r}0 K03Xr}0 K03r}0 K03r}0 K03s}0 K038s}0 K03ps}0 K03s}0 K03s}0 K03t}0 K03Pt}0 K03t}0 K03t}0 K03t}0 K030u}0 K03hu}0 K03u}0 K03u}0 K03v}0 K03Hv}0 K03v}0 K03v}0 K03v}0 K03(w}0 K03`w}0  %%%( UQU5 0"##$%_(Y+,05=k?AB5FMN\PQFSSYc[\aim4s}I͐@֖ߙI 6ѡͽ a\YQ(vtD(niM  ^ÏjڏI  (./1234679:<=>?@BHORUX[acegquwxy~"()/;LYl~ yJ?l3jO .!x!!N""##$<$$g%%&x&&M''((),--.(.r...//~//W11L22u33U455J666k77(8$>p????#@^@@@ A"ASAAAAAB/BWBBBBCC?DDD$ECEEE3FMNNN+OlOOPhPPPQdQjQ|QQR,RbRRRRRSNSSSSS+Zjvu+bؙĚKԛ9cDjZ/tYw s(=ʹPҺNdiq5aqqDz,Q 8Kfk7m /V[ !^$D*:$LQch-]CejWq,1IuSXqEJmr %Lv\zAYAnp 139Auw}(B`z $04=?oqwBDJa4?AG[gi4_~&4 '2^ ;  % @ D     )WINa]o 27iބ37I}O[mԆ Q|ezԌ܌^h/y I   !"#$%&')*+,-058;ACDEFGIJKLMNPQSTVWYZ\]^_`bdfhijklmnoprstvz{|}     !#$%&'*+,-.0123456789:<=>?@ABCDEFGHIJKMNOPQRSTUVWXZ[\]^_`abcdefghijkmnopqrstuvwxyz{|}  H#3:Nq5 ] v XXXX !(!!l,b$l?xK-}*1@(  f  c 6A!SHANDONB S  ?s`8t _Hlt267921118_Hlt267921119 OLE_LINK10 OLE_LINK11_Hlk267059321 OLE_LINK8 OLE_LINK9 OLE_LINK33 OLE_LINK4 OLE_LINK6 OLE_LINK7KKYYzz@@ LL^^.+%&T&1|22t<2u4|<||<|<<|L T7<f 2W2W9WWWW~Y~YY\]]$]^^{Ӏ؈++g ssJJ     !"#$%&'()*r 8W=W=WWWWYYY\#](](]^^{ 33s%%wwNN   !"#$%&'()*=*urn:schemas-microsoft-com:office:smarttags PlaceType= *urn:schemas-microsoft-com:office:smarttags PlaceNameB%*urn:schemas-microsoft-com:office:smarttagscountry-region8(*urn:schemas-microsoft-com:office:smarttagsCity9**urn:schemas-microsoft-com:office:smarttagsState9+*urn:schemas-microsoft-com:office:smarttagsplace<*urn:schemas-microsoft-com:office:smarttagschmetcnvV)*urn:schemas-microsoft-com:office:smarttags PersonNamehttp://www.microsoft.com <3 012009201033000000332990006098200074164000a Cao ChangqiuFalseHasSpaceinNegative NumberType ProductID SourceValueTCSCTrueUnitName+*) (*+%++*+ + + ++ +%     +++%   +%    +(+(+(DNDGHKfijrx{w{p4 v e k l q  MW&qz######?$C$$$$$Z%b%c%h%'''')(-(((((4)<)=)B)x++----7.>.?.E.t1{1|111111T2\2]2g2h2n2o2w2222233;3D334|5555555566 6*6+61626:6h6o6p6w66666Z7`7]@`@a@d@@@@@@@@A\AeAAA*B1BjBqBBB CCLCUCCCCCCCDDKDxD~DDDDDDDDDEEEECEFEJJJJFKOKeUpUwV}VVV2W8WWWXXXXXXXX~YY&[.[\\q\w\]#]]]L`V`eeggEjMjTkZk|lllmmmAnMnnnzz{{{|֗oy .jrX`/7 IZ.1S\ 4=@I;D4=ru~JM is'KT##,#&/ZfOY4=@I}&,HN'( *-.1JN !&+`gmov!   '?H..////g4i4??EE@VV\\^?_``ccnncvkvyy{ {N~Z~hpŁЍ؍;CˎӎӘ֘em,4'+s33333333333333333333333333333333333v*  s y ~ )Qv2D(?Wn}\)Zb]xz? G m H!!!""M####0$?$n$$$$$%K%Z%%%%%%%''2'X''''()(X(p(((((')4)^)r)))0Y0Z000t1112G2222;3i3333L4d444 5|5555 6T6h66667(7<777??I@w@x@@@@@@@@A)ALAOAAAAAAAAABB"B2BbBrBBBBBECCCCCCCCDDgDjDpDDDDDDDDDEEE EE,E?EqEEKKzÉ wۋ܋BlGxIl Swɤ/lx<u{f׳J-qζs9c}k/WY5*Qk+<~(XoBmz7\ra|&'+^z*2<Uiu|qD}NDC~(B* A@eNrޚMr0Liv@KS}@07J A5TV`H2cr >evV %V[S& e;7v`R70^uEY`Q\F`9iUԽ^ c"V$FB`[z.1nrvr VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l--^-`o(()  ^` hH0 e e^e` hH. E  E ^E ` hH. %  % ^% ` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.8^8`o(. \^`\hH) \^`\hH. ` \^` `\hH.  \^ `\hH)  \^ `\hH. L\^L`\hH. \^`\hH) \^`\hH.9^9`o(() \^`\hH) \^`\hH. a\^a`\hH.  \^ `\hH)  \^ `\hH. M\^M`\hH. \^`\hH) \^`\hH.0^`0o(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(0 H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH. ^` o(hH.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .p^p`PJo(() P\^P`\hH) \^`\hH.  \^ `\hH. < \^< `\hH)  \^ `\hH. \^`\hH. (\^(`\hH) \^`\hH.0^`0PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.hh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.--^-`o(() ^` 0e e^e` .E  E ^E ` .%  % ^% ` 0 ^` . ^` . ^` 0 ^` .^`PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH. ^` PJo(.  ^` hH0  ^` hH.  ^` hH. `  ` ^` ` hH0 @  @ ^@ ` hH.    ^ ` hH.  ^` hH0  ^` hH.e;7S&iU`[c"V A5vV %\FR7~}|1nrcr uEN        U        TL        ^n                         4S        |d0]        kP                                ހ        '&#: 9^} 5JMJ%Q6RCcTpVR[bc]o}_.o/pxpCvPwnz|= lI'9ezZ&r]jVOx%?WX}YfE  = l m z   ' , - l q v { | } #$;L]cdu#)*y ()Q`ouv%78*<=z !'9:e2;CDZahi (IJWbmn}.CDZhv'2=L[\ ()Zk|bo|o\]yz?FLX^_suw      G S Z f l m !! !,!3!?!F!G!!!!<""""##M#Y#d#n#z#########0$>$?$n$x$$$$$$$$%%%%K%Y%Z%%%%%%%%%%%:&&&''2'W'X'^'j'v'x'z'''''''''((()(X(b(l(n(p(((((((((')3)4)^)f)n)p)r))))/0D0Z0p00000001$1*1,1.1/1H1]1i1o1q1s1t11111111232=2B2D2F2G222222222233 3 3 33'3136383:3;3i33333333333333L4Q4Y4^4`4b4c444 5051575C5L5M5f5r5{5|5555556 6 6T6^6g6h66666666667 77(727;7<77777????@B@C@D@E@F@G@H@I@T@U@V@W@X@Y@e@n@t@x@~@@@@@@@@@@@@@@AHALAPATAUAfAAAAAAAAAAAAABBB!B"B2BUBYB]BaBbBrBBBBBBBBBBBBBBBBBBBCCCCCC4C:C>CDCECVC}CCCCCCCCCCCCCCCCCCDDDDDD D!D"D#D$D5D6D7D8D9D:DLDcDgDkDoDpDDDDDDDDDDDDDDDEEE EE,E2E8E>E?EKE]EaEeEiEjEpEqExE|EEEFCJKgTzƈ͈̈ #*+4<DLTU\cjryzÉ "#7K_efsӊ&:@AG[ouvȋڋۋ܋%4:ABl{nj֌ &Oxďʏя؏ڏۏ 5=?GOYZu|~ƐАѐאߐ/Is  8EKZ\ḷף ,7=?ISwŤǤɤʤ /klx(<st-:IJcuĴִ 2BTcdܵ-<KZhiŶƶ8J\npqķҷ߷ '45ظ%4CR`a}̹ڹ=IUcpqƺǺ5DSbpq̻ۻ!3ACDZ\^`abļʼϼм*+IXgw$%kyVWXY_xyz{ &./ABHNO\]djk 45;ABPQYabcdefgy{)*189STZ`abcdefghovwxyz{| (0123?KLMNOPQjkryz{|}~*+4;<}~"#$%&'(TUVWXnov~$%&'/789:FPQRSTUVijklm56=DE]^elm .09ABlmsyz  !",67[\cjklmnopqr|"*+,-./012:BCDEFGH[\dlmnopqr #$&-./0123`akuv#+,<=DKLMNOPQRS[cdefghijku/]^r'=>Q{|NOc9:YQRSTUc %ijklmVWXn} #+3:BDNOciqx /01234;<STUVWX^_nopqrs{|%&'=Li18@GMWYZ[\]^_`abiqy ()*+,-56EFGHIJRSabcdefno./0ESp !"#$,-./01234HLMNOYZxyz "*2:DEFGHIJKLjklmnvwxyz{|}~%123456MSYZ 28:;hrz{Z[\uvw| .5;< !)123?LMNOPQRSTU%&FGHVhijrz{|$%&'()U\cd =CIJx| 6<BCquyz,289KOSTUVWXnopq$*01ACGH\^abcdef|}~Nz{| %&=>tH%a2a2a2a2a2YTa24a2a2a2 0a2a2)r||@IJJJ@{Tvv VWZZZZZZZZnnddd@ @$@0@ "H@f@@@@@@@ @ @UnknownGz Times New Roman5Symbol3& z ArialKE  .DFKai-SBPMingLiU;[SOSimSunC .PMingLiUe0}fԚ9: ZWAdobeF3z Times] Times-BoldTimes New Roman_ Times-RomanTimes New RomanU Arial Unicode MSArial;ўSOSimHei?5 z Courier New[ (DFPFangSongW4-B5PMingLiU?E  eckwiSO_GBKўSO;Wingdings FfFa{' {' !xxd**2qHX?O2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky_o(u7bh                  Oh+'0(< P\ |  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe application Normal.dot ΢û28Microsoft Office Word@@*0GU-@D[3-@ *.{' ՜.+,D՜.+,  `h Wonderful Sky  8@ _PID_HLINKSARF http://www.cninfo.com.cn/~?mailto:xhzy@xhzy.com~OGhttp://www.xhzy.com/~yPmailto:guolei@xhzy.com~  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !#$%&'()+,-./01>Root Entry F*.@Data "(1TableWordDocumentBSummaryInformation("DocumentSummaryInformation8*CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q